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Abstract
Background
The proportion of women undergoing induction of labour (IOL) has risen in recent decades,
with significant variation within countries and between hospitals. The aim of this study was
to review research supporting indications for IOL and determine which indications are sup-
ported by evidence and where knowledge gaps exist.
Methods
A systematic scoping review of quantitative studies of common indications for IOL. For each
indication, we included systematic reviews/meta-analyses, randomised controlled trials
(RCTs), cohort studies and case control studies that compared maternal and neonatal out-
comes for different modes or timing of birth. Studies were identified via the databases
PubMed, Maternity and Infant Care, CINAHL, EMBASE, and ClinicalTrials.gov from
between April 2008 and November 2019, and also from reference lists of included studies.
We identified 2554 abstracts and reviewed 300 full text articles. The quality of included stud-
ies was assessed using the RoB 2.0, the ROBINS-I and the ROBIN tool.
Results
68 studies were included which related to post-term pregnancy (15), hypertension/pre-
eclampsia (15), diabetes (9), prelabour rupture of membranes (5), twin pregnancy (5), sus-
pected fetal compromise (4), maternal elevated body mass index (BMI) (4), intrahepatic
cholestasis of pregnancy (3), suspected macrosomia (3), fetal gastroschisis (2), maternal
age (2), and maternal cardiac disease (1). Available evidence supports IOL for women with
post-term pregnancy, although the evidence is weak regarding the timing (41 versus 42
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weeks), and for women with hypertension/preeclampsia in terms of improved maternal out-
comes. For women with preterm premature rupture of membranes (24–37 weeks), high-
quality evidence supports expectant management rather than IOL/early birth. Evidence is
weakly supportive for IOL in women with term rupture of membranes. For all other indica-
tions, there were conflicting findings and/or insufficient power to provide definitive evidence.
Conclusions
While for some indications, IOL is clearly recommended, a number of common indications
for IOL do not have strong supporting evidence. Overall, few RCTs have evaluated the vari-
ous indications for IOL. For conditions where clinical equipoise regarding timing of birth may
still exist, such as suspected macrosomia and elevated BMI, researchers and funding agen-
cies should prioritise studies of sufficient power that can provide quality evidence to guide
care in these situations.
Introduction
Induction of labour (IOL) has been on the rise over recent decades [1, 2], with significant vari-
ation within countries and between hospitals [1, 3, 4]. In Australia, the IOL rate rose from
27.3% in 2012 to 31.1% in 2016 [1].
IOL is generally undertaken with the aim of decreasing maternal and/or fetal morbidity
or mortality i.e. when the risks of continuing the pregnancy to either mother or fetus are
considered greater than the risks associated with planned birth [5]. For example, women are
commonly induced for post-term pregnancy to reduce the risk of stillbirth [6]. Women with
premature rupture of membranes are induced to decrease incidence of maternal sepsis and
neonatal infection secondary to chorioamnionitis [7], women with preeclampsia to reduce the
risk of stillbirth and severe maternal morbidity (renal failure, liver failure, coagulopathy, pul-
monary oedema, eclamptic seizures) [8] and women with diabetes are induced to minimise
macrosomia-associated birth complications and stillbirth risk [9].
While some indications for IOL are supported by high level evidence, others are not [10]. A
systematic review of the evidence of indications by Mozurkewich et al. [10] conducted in 2008
found that the evidence at the time was insufficient to support IOL for women with common
indications such as diabetes, twin gestation, suspected fetal macrosomia and oligohydramnios.
The review called for further research to obtain a clearer picture of the risks and benefits asso-
ciated with IOL [10].
In the 10 years since the initial review by Mozurkewich et al. [10], there continues to be
debate about the acceptable use of IOL. There is no agreed external standard [11], and clinical
guidelines vary considerably, both nationally and internationally [12–17]. The recent ARRIVE
trial [18], which compared outcomes for low risk nulliparous women associated with IOL at
39 weeks (between 39+0 and 39+4) versus expectant management, seems to have further
divided the maternity community in relation to IOL timing [19]. While this trial did not find
any differences between the two groups for its primary outcome, that is, a composite of perina-
tal death and severe neonatal complications, it did find that IOL was associated with a reduc-
tion in caesarean section (CS) rate by 4%. This is at odds with some population studies that
show that IOL is associated with a rise in CS rate [20]. Regardless of whether IOL is associated
with a rise or reduction in CS rates, it is associated with increasing rates of early term birth
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[21], and its negative impact on child development [22]. Furthermore, IOL is often associated
with a less positive birth experience for women compared to spontaneous onset of labour [23–
25]. As such, the circumstances in which to offer a woman an IOL should be informed by the
best available evidence.
The aim of this scoping review was to map the evidence in relation to indications for IOL
and determine which are supported by evidence and where knowledge gaps exist. By building
on the review by Mozurkewich et al. [10], this study presents a comprehensive overview of the
available evidence to date.
Method
We undertook a systematic scoping review [26–29], informed by the method used by Mozur-
kewich et al. [10], and following the PRISMA-ScR reporting guidelines for systematic reviews
as outlined in our protocol developed before the review commenced. The aim of a scoping
review is to map the literature relevant to a broad research topic to gain insight into the nature
of the evidence and identify research gaps [26, 27, 29].
Inclusion and exclusion criteria
We included quantitative studies that explored common indications for IOL, specifically: post-
term pregnancy, premature rupture of membranes (PROM), twin pregnancy, antepartum
haemorrhage, chorioamnionitis (including suspected), cholestasis of pregnancy, alloimmune
disease or Rh disease, intrauterine growth restriction (IUGR), fetal distress, oligohydramnios,
fetal gastroschisis, fetal macrosomia, fetal death, chronic/gestational hypertension, preeclamp-
sia, diabetes, maternal age, elevated maternal body mass index (BMI), and other more uncom-
mon maternal obstetric or medical indication (e.g. maternal cardiac disease, maternal
melanoma, breast cancer, history of fast labour).
For each indication, we included systematic reviews/meta-analyses, randomised controlled
trials (RCTs), prospective and retrospective cohort studies, and case control studies that com-
pared maternal and neonatal outcomes for different modes or timing of birth i.e. IOL versus
expectant management (EM); IOL versus immediate birth by caesarean section (CS); IOL at
different time points (e.g. at 41 versus 42 weeks); and EM versus expedited birth.
To be included in the review, studies had to report on one or more of the following out-
comes of interest: mode of birth, maternal morbidity, and fetal or neonatal morbidity and
mortality. Following Mozurkewich et al. [10], maternal morbidity was defined as chorioam-
nionitis, endometritis, severe perineal trauma, blood transfusion, emergency CS or prolonged
hospitalisation. Neonatal morbidity was defined as admission to a neonatal intensive care unit
(NICU), 5-minute Apgar score <7, respiratory distress syndrome (RDS), shoulder dystocia,
birth injury (as defined by the authors), meningitis, pneumonia, hypoxic ischaemic encepha-
lopathy, meconium aspiration syndrome, or sepsis.
Studies were excluded if they were reported on in a systematic review or meta-analysis
already included (as not to double count), where full text was not available or accessible, or if
not published in English. Studies that compared different methods of IOL or evaluated IOL
outcomes in the absence of a medical indication (e.g. maternal choice, routine IOL at 39
weeks) were also excluded.
Search strategy
To identify studies for inclusion we searched the databases PubMed (including Cochrane
Library), Maternity and Infant Care (OVID), CINAHL, EMBASE and ClinicalTrials.gov from
April 2008 to April 2018, which was then updated with an additional search until November
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2019 to ensure the review was up to date at the time of publication. The databases were
searched using the terms ‘labour induction’, ‘induction’ and ‘induction of labour’ in combina-
tion with the indications listed above. Following this we examined the reference lists of
included articles for further studies. We also included studies that met our inclusion criteria
previously included in the review by Mozurkewich et al. [10], which covered the period from
January 1980 to April 2008 and used a comprehensive search strategy. This approach means
that our review presents a comprehensive overview of the evidence from 1980 to date.
Data collection and extraction
All articles were screened for eligibility against the review criteria by reading the title and
abstract by one reviewer (first author). All full text articles were reviewed by two authors to
determine suitability for inclusion (See Fig 1). For each of the included studies, data were
extracted by two reviewers using a purposely designed template that followed the PICO
framework (method, population, intervention and comparator, outcomes) [30]. The quality
of included studies was assessed by two reviewers independently, using the Cochrane the Risk
of Bias in Randomised Trials Tool (RoB 2.0 tool) for RCTs [31], the Risk Of Bias In Non-ran-
domised Studies of Interventions tool (ROBINS-I) for non-randomised studies [32] and the
ROBIN tool [33] for systematic reviews.
Fig 1. Flow of papers through review.
https://doi.org/10.1371/journal.pone.0228196.g001
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Results
Our search identified 2554 papers for screening, of which 272 articles were identified for full
text review. We also reviewed the 34 studies identified by Mozurkewich et al. [10], of which
28 were included for full text review (we could not access full text for the remaining six). In
total, 300 full text studies were reviewed, of which 68 were included (see Tables 1 and 2). Only
six of the studies included in the review by Mozurkewich et al. [10] were included here, as the
remaining were studies already included in more recent systematic reviews, or were systematic
reviews that had been superseded by more recent reviews.
Included studies are listed in Tables 1 and 2. We did not identify any studies for inclusion
in relation to fetal alloimmune disease or Rh disease, antepartum haemorrhage, (suspected)
chorioamnionitis, or fetal death and only one study in relation to ‘other’ maternal medical
indications, about maternal cardiac disease. The evidence for each indication for IOL is sum-
marised below.
Post-term pregnancy
There were 15 studies related to IOL for post-term pregnancy (> 40 weeks). These included a
Cochrane review [6], a systematic review [34], an RCT [35], a prospective cohort study [36],
nine retrospective cohort studies [37–45], and two secondary analyses of cohort studies [46,
47]. The Cochrane review assessed the effects of a policy of IOL at or beyond term compared
with a policy of awaiting spontaneous labour (or until planned birth is deemed necessary) on
maternal and neonatal outcomes [6]. This review includes 30 RCTs, with 12,479 women [48–
77]. The majority of trials (about 75% of participants) adopted a policy of IOL at� 41 weeks.
IOL was associated with fewer perinatal deaths (2 vs 16) (risk ratio (RR) 0.33, 95% confidence
interval (Cl) 0.14 to 0.78), lower NICU admissions (RR 0.88, 95% Cl 0.77 to 1.01), fewer babies
with Apgar scores<7 at five minutes (RR 0.70, 95% Cl 0.50 to 0.98), and fewer CS (RR 0.92,
0.92, 95% Cl 0.85 to 0.99). The number needed to treat in order to prevent one perinatal death
was 426. There was no significant difference between groups for perineal trauma (RR 1.09,
95% Cl 0.65 to 1.83), postpartum haemorrhage (RR 1.09, 95% Cl 0.92 to 1.30), length of mater-
nal hospital stay (average mean difference -0.34 days, 95% Cl 1.00 to 0.33), or neonatal trauma
(RR 1.18, 95% Cl 0.68 to 2.05). IOL was associated with an increase in operative vaginal births
(RR 1.07, 95% Cl 0.99 to 1.16), in particular for IOL at< 41 weeks. Systematic reviews con-
ducted prior to this Cochrane review included the same studies and, with the exception of one
study [34], were excluded [12, 78–80]. The additional systematic review included reviewed the
RCTs within the Cochrane review [6] and compared outcomes associated with IOL at 41
weeks versus 42 weeks [34]. This review identified four RCTs relevant to these timeframes and
concluded that there was insufficient evidence to support IOL at 41 weeks instead of 42 weeks.
A recent RCT not included in these systematic reviews compared IOL at 41 weeks with EM
until 42 weeks found that IOL was associated with reduced adverse perinatal outcomes (1.7%
vs 3.1%, absolute risk difference, -1.4%, 95% CI -2.9 to 0.0), however, this study was under-
powered to demonstrate superiority of IOL at 41 weeks [35].
The remaining studies were cohort studies, mostly assessed as of moderate or severe risk of
bias. In relation to outcomes associated with IOL at different gestational ages, three included
retrospective cohort studies compared outcomes under different policy periods [38, 41, 45].
Bleicher et al. [41] compared outcomes for women who gave birth under a policy of IOL at 42
weeks (n = 968; from 2008–2009) with those who gave birth under a policy of IOL at 41 weeks
(n = 962; from 2012–2013). This study found that, both the overall CS rate as well as the CS
rate for women who underwent IOL, was lower during the 41 week policy period than during
the 42 week policy period (15% vs 19.4%, p = 0.014 and 19% versus 27%, p = 0.007). IOL at 41
Indications for induction of labour
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Table 1. Included randomised controlled trials and meta-analyses of trials.
Author,
Publication
year
Indication Study design Country and Setting Aim and Participants Main Findings Risk of
bias
Gurung et al.
(2013) [163]
Cholestasis A Cochrane review of
randomised and quasi
randomised controlled
trials
UK. While this review
identified 21 RCTs for
inclusion, only one RCT is
relevant to our review and
compared outcomes for early
term delivery versus EM (the
PITCH 2012 trial in the UK)
and the findings of this study
are reported here (N = 63)
N = 63 To evaluate the
effectiveness and safety of
interventions in women with
cholestasis of pregnancy. Includes
one RCT that compared outcomes
for early term birth (n = 30) (IOL
between 37+0 and 37+6) versus
EM (n = 33).
There were no stillbirths or
neonatal deaths in either group and
no significant differences in CS (RR
0.68), passage of meconium-stained
liquor (RR 0.55) or admission to
NICU (RR 0.55).
Low
Boulvain et al.
(2009) [145]
Diabetes (either type I
or type II), or GDM
Cochrane review of
RCTs
1 RCT included. Setting not
specified in Cochrane review.
N = 200 To compare outcomes for
IOL (n = 100) versus EM (n = 100)
at term (�38 weeks) for diabetic
(either type I or type II, or GDM)
pregnant women treated with
insulin. Women with other
complications were excluded.
No significant differences between
the two groups in terms of CS (RR
0.81), the risk of macrosomia was
reduced in the IOL group (RR 0.56)
and three cases of mild shoulder
dystocia were reported in the EM
group. No other perinatal
morbidity was reported.
Low
Biesty et al.
(2018) [9]
Diabetes—GDM Cochrane review of
RCTs
1 RCT included. Multi-centre
study conducted between 2010
and 2014, with teaching
hospitals from Italy, Slovenia
and Israel.
N = 425 To evaluate maternal and
perinatal outcomes after IOL
(n = 214) versus EM (n = 211) in
pregnant women with GDM at
term (included trial enrolled
women at 38–39 weeks, excluded if
estimated fetal weight over 4kg).
Women with other complications
(including diabetes type I or II)
and previous CS were excluded.
No significant difference between
the two groups in terms of CS rates
(RR 1.06; 12.6% in the IOL group
versus 11.7% in the expectant
group), or other maternal or
neonatal outcomes.
Low
Sutton et al.
(2014) [146]
Diabetes—GDM Secondary analysis of an
RCT that compared
different treatments for
mild GDM.
Hospitals in North America
that are members of the
NICHD Maternal-Fetal
Medicine Units Network
N = 679 (of the original 958
women) To compare CS rates
associated with IOL (n = 220)
versus EM (n = 459).
IOL was not associated with
increased rates of CS at 37, 38, or 39
weeks, but was associated with a
3-fold increase in CS rates at 40
weeks and beyond.
Low
Grant et al.
(2013) [182]
Gastrochisis A Cochrane review of
RCTs; studies with quasi
randomised design or
cross-over design were
excluded
UK. Single centre RCT
conducted between May 1995
and September 1999
N = 42 To assess the effects of
planned preterm birth (< 37
weeks) for fetal gastroschisis by
comparing outcomes for IOL at 36
weeks (n = 21) and spontaneous
onset of labour (n = 21)
There was no significant benefit or
adverse effect associated with
elective preterm birth, but the
included trial was underpowered to
detect clinically important outcome
differences.
Low
Amorim et al.
(2017) [120]
Hypertension—Severe
preeclampsia
Cochrane review of
RCTs; quasi RCTs or
studies with cross-over
design were excluded
No studies identified for
inclusion.
To compare planned CS versus
IOL for severe preeclampsia
No studies identified for inclusion. No
included
studies
Chappell et al.
(2019) [122]
Preeclampsia between
34–37 weeks
RCT England and Wales. Multi-site
including 46 maternity units
N = 901 To compare planned birth
(usually IOL) (n = 448) versus EM
(n = 338) in women with late
preterm pre-eclampsia from 34 to
37 weeks and a singleton or
dichorionic diamniotic twin
pregnancy.
Planned birth reduced maternal
morbidity and severe hypertension
(65% vs 75%, RR = 0.86, 95% CI
0�79–0�94; p = 0�0005), but more
neonatal admissions for
prematurity (42% vs 34%, RR 1�26,
1�08–1�47; p = 0�0034)
Low
Churchill et al.
(2013)† [119]
Hypertension—Severe
preeclampsia between
24 and 34 weeks
Cochrane review of
RCTs; quasi randomised
studies were excluded
4 included RCTs from Europe,
USA and South Africa
N = 425 To compere planned early
birth (by IOL or CS) (n = 222)
versus EM (n = 203)
An expectant approach may be
associated with decreased
morbidity for the baby. There was
insufficient data for reliable
conclusions about the comparative
effects on most outcomes for the
mother.
Low
Vigil-De-
Gracia et al.
(2013) [121]
Hypertension—Severe
preeclampsia between
28 and 33 weeks
RCT Latin America. Multisite study
including 8 tertiary teaching
hospitals between 2010 and
2012
N = 267 To compare planned early
birth (n = 133) versus EM
(n = 134)
EM was not associated with
neonatal benefit and may increase
the risk of abruption and small for
gestational age.
Low
(Continued)
Indications for induction of labour
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Table 1. (Continued)
Author,
Publication
year
Indication Study design Country and Setting Aim and Participants Main Findings Risk of
bias
Cluver et al.
(2017) [118]
Hypertension—all
forms from 34 weeks to
term
Cochrane review of
RCTs; studies with quasi
randomised design or
cross-over design were
excluded
5 included RCTs from the
Netherlands, India; USA,
Saudi Arabia and Egypt
(including Hypitat I and II)
N = 1819 To compare planned
early birth (n = 915) versus EM
(n = 904)
Planned early birth is associated
with less composite maternal
morbidity and mortality. There is
no clear difference in the composite
outcome of infant mortality and
severe morbidity; however, this is
based on limited data (from two
trials) assessing all hypertensive
disorders as one group.
Low
Tajik et al.
(2012) [211]
Hypertension and mild
preeclampsia between
36 and 41 weeks
Post hoc analysis of RCT
(HYPITAT-I)
The Netherlands. N = 756 (IOL group = 377; EM
group = 379) To assess whether
cervical ripeness should play a role
in the decision for IOL.
The superiority of IOL in
preventing high-risk situations
varied significantly according to
cervical favourability.
Low
Walker et al.
(2016) [171]
Maternal age RCT UK. Multi-centre study
including 39 Centers between
August 2012 to March 2015
N = 619 To test if IOL at 39 weeks
reduces CS rates for nulliparous
women of advanced maternal age
(� 35) by comparing outcomes for
IOL (n = 305) with EM (n = 314).
Women who had undergone in
vitro fertilization with the use of
donor eggs were excluded.
No significant differences in the
two groups in terms of CS rates
(32% in IOL group vs 33% in EM
group; RR 0.99), % of women who
had a vaginal birth with the use of
forceps or vacuum (38% vs 33%, RR
1.30), the women’s experience of
childbirth, or adverse maternal or
neonatal outcomes. There were no
maternal or infant deaths.
Low
Boulvain et al.
(2016)‡ [174]
Macrosomia—
Suspected
Cochrane review of
RCTs between 1995 and
2015; studies with quasi
randomised design or
cross-over design were
excluded
4 included RCTs that include
participants from France,
Switzerland Belgium, Israel,
USA and UK.
N = 1190 To compare outcomes
associated with IOL (n = 590)
versus EM (n = 600) for suspected
fetal macrosomia between 37 to 40
weeks in non-diabetic women.
IOL had no clear effect on the risk
of CS (RR 0.91) or instrumental
birth (RR 0.86), but did reduce
shoulder dystocia (RR 0.60) and
fracture (any) (RR 0.20). There was
no strong evidence of any
difference between groups for
measures of neonatal asphyxia: low
infant Apgar scores (<7 at 5
minutes) (RR 1.51) or low arterial
cord blood pH (RR 1.01). There
was no perinatal mortality, and no
differences in the groups in terms
of portion of newborns with
intraventricular haemorrhage (RR
1.06), nor neonatal intensive care
admissions (RR 0.66).
Low
Keulen et al.
(2018) [34]
Post-term pregnancy Systematic review Reviewed evidence from RCTs
included in Cochrane review
by Middleton, Shepherd [6]
N = 4 RCTs To compare outcomes
associated with IOL at 41 weeks
versus 42 weeks.
The incidence of potentially
gestational age associated perinatal
mortality between 41 and 42 weeks
was 0/2.444 (0%) for the IOL group
versus 4/2.452 (0.16%) in the EM
group (number needed to treat was
613). This review concluded that
there is not sufficient evidence for
IOL at 41 weeks instead of 42
weeks.
Low
Keulen et al.
(2019) [35]
Post-term pregnancy RCT The Netherlands. Multi-site
study including 123 primary
care midwifery practices and
45 hospitals with data
collected between 2012 and
2016.
N = 1801 low risk women with an
uncomplicated singleton
pregnancy. To compare IOL at 41
weeks (n = 900) versus EM until 42
weeks (n = 901)
IOL was associated with reduced
adverse perinatal outcomes (1.7%
vs 3.1%, absolute risk difference of
1.4%, 95% CI -2.9 to 0.0, p = 0.22
for non-inferiority). No significant
difference was found in composite
adverse maternal outcomes or CS
rates.
Low
(Continued)
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Table 1. (Continued)
Author,
Publication
year
Indication Study design Country and Setting Aim and Participants Main Findings Risk of
bias
Middleton
et al. (2018)
[6]
Post-term pregnancy Cochrane review.
Cluster RCTs, quasi-
RCTs, or cross-over
design were excluded.
30 RCTs (1969–2015) from
Norway, China, Thailand, the
USA, Austria, Turkey,
Canada, UK, India, Tunisia,
France, Finland, Spain,
Sweden and the Netherlands.
N = 12,479 To assess the effects of a
policy of IOL at or beyond term
compared with a policy of awaiting
spontaneous labour (or until
planned birth becomes required)
on pregnancy outcomes for infant
and mother. Only trials including
women at low risk for
complications were included.
IOL was associated with fewer
perinatal deaths (RR) 0.33) (2 vs
16), lower NICU admissions (RR
0.88), fewer babies had Apgar
scores <7 at five minutes (RR 0.70),
and fewer CS (RR 0.92). The
number needed to treat to in order
to prevent one perinatal death was
426. There was no significant
difference between groups for
perineal trauma (RR 1.09),
postpartum haemorrhage (RR
1.09), length of maternal hospital
stay, or neonatal trauma (RR 1.18).
IOL was associated with an increase
in operative vaginal births (RR
1.07), in particular for IOL at < 41
weeks.
Low
Bond et al.
(2017) [82]
PROM, preterm Cochrane review of
RCTs; quasi RCTs were
excluded
USA, the Netherlands,
Mexico, Albania, Australia,
New Zealand, Argentina,
South Africa, Brazil, UK,
Norway, Egypt, Uruguay,
Poland, and Romania
N = 3617 To compare outcomes
associated with planned early birth
by CS or IOL with EM for women
with PROM of<37 weeks with no
maternal or fetal contraindications
to EM.
In terms of neonatal outcomes,
there were no clear differences in
neonatal sepsis (RR 0.93), proven
neonatal infection with positive
blood culture (RR 1.24), and overall
perinatal mortality (RR 1.76), but
found that early birth was
associated with a higher rate of
neonatal death (RR 2.55),
respiratory distress syndrome (RR
1.26), need for ventilation (RR
1.27), and NICU admission (RR
1.16). In terms of maternal
outcomes, early birth was
associated with an increased rate of
CS (RR 1.26) and increased rate of
endometritis (RR 1.61), and
reduced incidence of
chorioamnionitis (RR 0.50).
Low
Middleton
et al. (2017)
[81]
PROM, at term A Cochrane review of
randomised and quasi-
randomised controlled
trials
23 RCTs (1990–2015) from
Pakistan, China, Scotland,
Canada, the UK, Australia,
Israel, Sweden and Denmark,
Brazil, Canada, Denmark,
Germany, India, Norway,
Serbia, Sweden, the
Netherlands, Turkey, USA,
and Zimbabwe.
N = 8615 To compare IOL
(immediate or within 24 hours)
with EM (no planned intervention
within 24 hours) for women with
PROM of�37 weeks with no
maternal or fetal contraindications
to EM.
Women who had IOL were at a
reduced risk of maternal infectious
morbidity (chorioamnionitis and/
or endometritis) than women who
had EM (RR 0.49), and their
neonates were less likely to have
early-onset neonatal sepsis (RR
0.73). No clear differences were
seen for the risk of CS (RR 0.84);
serious maternal morbidity or
mortality (no events); definite
early-onset neonatal sepsis (RR
0.57); or perinatal mortality (RR
0.47).
Low
Bond et al.
(2015) [185]
Suspected fetal
compromise, incl.
intrauterine growth
restriction and
oligohydramnios
A Cochrane review of
randomised and quasi
randomised controlled
trials
3 RCTs with participants from
the Netherlands and Sweden
N = 546 To assess the effects of
early birth (n = 269) versus EM
(n = 277) of suspected
compromised fetus at term (� 37
weeks) on neonatal, maternal and
long-term outcomes.
There are no major differences in
major neonatal and maternal
outcomes between the two groups.
Low
Stock et al.
(2016) [186]
Suspected fetal
compromise
A Cochrane review of
RCTs; studies with quasi
randomised design or
cross-over design were
eligible but non
identified
1 RCT included conducted
between 1993–2001 in 69
hospitals in 13 countries
(Belgium, Cyprus, Czech
Republic, Germany, Greece,
Hungary, Italy, Netherlands,
Poland, Portugal, Saudi
Arabia, Slovenia, UK).
N = 548 women (588 babies) To
assess the effects of immediate
(n = 296) versus deferred (n = 291)
birth of preterm babies (24–36
weeks) with suspected fetal
compromise (and uncertainty
about whether to deliver early or
not) on neonatal, maternal and
long-term outcomes.
For preterm babies with suspected
compromise and uncertainty about
whether to deliver or not, there
appears to be no benefit to
immediate birth.
Low
(Continued)
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weeks was also associated with a significant reduction in 1st and 2nd degree perineal lacera-
tions and neonatal readmission within 30 days of discharge. Similarly, Wolff et al. [45] com-
pared outcomes for women who gave birth under a policy of IOL at 41+2 weeks (2012)
(n = 8545) versus those who gave birth under a policy of IOL at 42 weeks (2010) (n = 9713).
This study found a significant reduction in the rate of CS between 2010 and 2012 (p = 0.05),
and a non-significant reduction in perinatal mortality of 60% (from 10 to 3). There were no
significant differences in instrumental birth numbers or perinatal outcomes. Kassab et al. [38]
compared CS rates associated with a policy of IOL at 41+3 days (n = 124; August 2006 and
March 2007) versus a policy of IOL at 42 weeks (n = 227; April 2007 and July 2008), and found
that the earlier IOL policy was associated with lower CS rates (p = 0.04) for nulliparous
women.
Two cohort studies compared CS rates associated with IOL prior to 41 weeks versus IOL at
41 weeks [36, 47], also presenting opposing findings. A prospective cohort study by Haq et al.
[36] compared CS rates for IOL at 40 weeks (n = 39) with IOL at 41 weeks (n = 39), and found
that IOL at 41 weeks was associated with lower CS rates (16% vs 29%, p< 0.0001). Conversely,
McCoy et al. [47] conducted a secondary analysis of a prospective cohort study to compare CS
rates for IOL at term (between 37–40+6) (n = 700) with IOL at>41 weeks (n = 154) among
women with an unfavourable cervix (Bishop score of<6 and cervical dilation <2 cm). This
study found an increased risk of CS for women induced at>41 weeks versus those induced at
term (46.8% vs 26.0%, p< .001).
The remaining seven papers included cohort studies that compared IOL with expectant
management (EM) (spontaneous onset of labour or IOL if it becomes indicated) [37, 39, 40,
42–44, 46]. Mya et al. [46] conducted a secondary analysis of two multi-country surveys con-
ducted by the World Health Organization (WHO) on maternal and newborn health to com-
pare outcomes of IOL at 41 weeks (n = 4332) with EM (n = 26,720) (spontaneous onset of
labour or birth at> 41 weeks). Compared to IOL, EM was significantly associated with
decreased risk of CS in both databases (OR 0.70 and IOR 0.67). A retrospective cohort study
by Mahomed et al. [37] compared CS rates associated with IOL at between 40 and 40+6 weeks
(n = 2153) versus spontaneous birth between 41 and 41+6 weeks (n = 5658) for nulliparous
women with uncomplicated singleton pregnancy, and found that CS rates were significantly
higher in the IOL group (OR 1.52; 21% versus 14.9%).
Four other retrospective cohort studies compared the mode of birth associated with IOL at
41+1 weeks to EM until spontaneous onset of labour or IOL at 42–42+6 weeks [40, 42–44].
While, based on a relatively small sample size of 483 women (n = 211 in the IOL group;
Table 1. (Continued)
Author,
Publication
year
Indication Study design Country and Setting Aim and Participants Main Findings Risk of
bias
Dodd et al.
(2014) [156]
Twin pregnancy Cochrane review of
RCTs; studies with
cross-over design were
excluded
2 included RCTs. A multi-site
study across Australia, New
Zealand and Italy, and a single
site study from Japan.
N = 271 and 542 infants To
compare elective birth by CS or
IOL from 37 week (n = 133) with
EM (n = 138) for women with an
otherwise uncomplicated twin
pregnancy. EM = IOL after 38
weeks, spontaneous onset of
labour, or CS close to 39 weeks.
No statistically significant
differences in CS, perinatal death or
serious infant morbidity, or
maternal death or serious maternal
morbidity.
Low
†review by Wang et al. (2017) [143] included the same studies.
‡review by Magro-Malosso (2017) [177] included the same studies with similar findings.
EM = expectant management; GDM = Gestational diabetes mellitus; IOL = Induction of labour; CS = Caesarean section; NICU = neonatal intensive care unit
https://doi.org/10.1371/journal.pone.0228196.t001
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Kohari et al.
(2017) [165]
Cholestasis Retrospective cohort
study
USA. Single centre study with
data from between 2005 and
2013
N = 186 To compare outcomes for
women who birthed under an
active management policy (2009–
2013) versus those who birthed
prior to the introduction of this
policy (2005–2008). All women
with bile acids >40 μmol/L and
diagnosis <36 weeks were
included.
The active management policy was
found to be associated with a
significant reduction in the
incidence of stillbirth (0% versus
3.4%, p = 0.035). There was no
difference in the age at birth, CS
rates or NICU admissions.
Moderate
Puljic et al.
(2015) [164]
Cholestasis Retrospective cohort
study
USA. Analysis of a national
dataset of 1,604,386 women
between 34 and 40 weeks in
California between 2005 and
2008.
N = 5545 (identified with
cholestasis). To characterise the
risk of infant and fetal death by
each additional week of EM versus
immediate birth in pregnancies
complicated by cholestasis.
Birth at 36 weeks gestation was
associated with lower perinatal
mortality.
Low
Bettikher et al.
(2016) [147]
Diabetes—GDM Retrospective cohort
study
Russia. Single centre study with
data from 2014.
N = 231 To evaluate the outcomes
of IOL (n = 43) versus
spontaneous labour (n = 188) in
women with GDM. No details
provided on the baseline
characteristics of the two groups.
No significant difference between
the two groups in terms of CS rate,
the frequency of uterine inertia,
uncoordinated contractions or
foetal distress.
Serious
Feghali et al.
(2016) [148]
Diabetes—GDM Retrospective cohort
study
USA. Single centre study with
data from January
2009-October 2012
N = 863 To compare CD rates in
women undergoing IOL at each
week of gestation with EM to a
later gestational age. Women with
previous CS or other
complications were excluded.
Moderate
Grabowska
et al. (2017)
[149]
Diabetes—GDM Retrospective cohort
study
Poland. Single centre study
with data from 2013–2014
N = 204 To compare the mode
birth for women with GDM who
underwent IOL (n = 96) versus
those with spontaneous onset of
labour (n = 32).
IOL did not increase the risk for
CS (25% versus 25%, p = 0.66).
Moderate
Hochberg et al.
(2019) [152]
Diabetes—GDM Retrospective cohort
study
Israel. Single site study with
data from between 2014 and
2016
N = 430 To compare maternal and
neonatal outcomes in women with
good glycemic controlled
gestational diabetes mellitus
(GDM) undergoing IOL at 37
+ 0–38 + 6 weeks (n = 193) versus
39 + 0–40 + 6 weeks (n = 237)
Rates of composite maternal
outcome and composite neonatal
outcome did not differ between
groups. There were higher rates of
hypertensive complications of any
kind and pre-eclampsia, in women
induced at early term (11.04% vs.
4.26%, p = 0.021, and 5.92% vs.
1.60%, p = 0.04, respectively).
Moderate
Melamed et al.
(2016) [150]
Diabetes—GDM Retrospective cohort
study
Canada. National dataset of all
birth between April 2012 and
March 2014
N = 6417 To compare outcomes
for those who underwent IOL at
38 or 39 weeks (for reasons related
to GDM) with those who were
managed expectantly. Women
with comorbid conditions or a
previous CS were excluded.
IOL at 38 or 39 weeks was
associated with a lower CS rates
but higher risk of NICU admission
when done at <39 weeks of
gestation
Moderate
Vitner et al.
(2019) [151]
Diabetes—GDM Retrospective cohort
study
Israel. Single site study with
data analysed from between
2007–2014
N = 880 To compare IOL at each
week of gestation versus EM for
GDM
IOL was associated with increased
risk for adverse composite neonatal
outcome or NICU admission when
done prior to 39 weeks. IOL at 37
weeks was associated with adverse
composite neonatal outcome (aOR
2.2, 95% CI 1.4–3.6) and NICU
admission (aOR 2.5, 95% CI 1.4–
4.4). At 38 weeks, with NICU
admission (aOR 2.0, 95% CI 1.4–
2.9), and at 39 weeks with fracture
of the clavicle.
Moderate
(Continued)
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Al-Kaff et al.
(2015) [183]
Gastrochisis Retrospective cohort
study
Canada. Analysis of Canadian
Paediatric Surgery Network
national database from 2005–
2013.
N = 519 infants To assess the
effect of mode and timing of birth
for fetal gastroschisis on neonatal
outcomes by comparing outcomes
for mode of birth (spontaneous
labour, n = 190; IOL, n = 280; CS,
n = 49) and timing of birth (�35
weeks, n = 8; 36–37 weeks,
n = 193;�38 weeks, n = 69).
Neither mode nor timing of birth
were associated with significant
benefits or adverse effects.
Low
Alanis et al.
(2008) [127]
Hypertension—Severe
preeclampsia between 24
and 34 weeks of
gestation
Retrospective cohort
study
USA. Single centre study with
data from between 1996 and
2006
N = 491 To describe the success
rate of and analyse differences in
neonatal outcomes with IOL
(n = 282) versus planned CS
(n = 209)
Neonatal outcomes were not
worsened by IOL although it was
rarely successful at under 28 weeks
of gestation.
Moderate
�Alexander
et al. (1999)
[130]
Hypertension—Severe
preeclampsia -very low
birth weight infants
(weights between 750
and 1500g)
Retrospective cohort
study
USA. Single centre study with
data from 1988 to 1997
N = 278 To compare IOL
(n = 145) with planned CS
(n = 133)
IOL in cases of severe pre-
eclampsia is not harmful to very
low birth weight infants.
Moderate
Amorim et al.
(2015) [124]
Hypertension—Severe
preeclampsia
Prospective cohort
study
Brazil. Single centre study
between August 2008 and July
2009
N = 500 To compare vaginal birth
(n = 159) and CS (n = 341) in
terms of maternal outcomes.
Labour was spontaneous in 110
patients (22%) and induced in 141
(28.2%)
CS was associated with severe
maternal morbidity, irrespective of
the presence of labour. The authors
suggest that Induction of labour
should be considered a feasible
option in these patients.
Moderate
�Blackwell
et al. (2001)
[131]
Hypertension—Severe
preeclampsia at < = 34
weeks
Case control study USA. Single centre study with
data from January 1991 to
December 1998
N = 215 To examine the success
rate of IOL, identify factors
associated with its success and
evaluate neonatal outcomes based
on induction success or failure. To
compare outcomes associated
with planned CS (n = 64), CS
following attempted IOL (n = 82),
and vaginal birth following
successful IOL (n = 69).
Induction success was significantly
associated with gestational age.
While, attempted IOL did not
appear to increase neonatal
morbidity, induction was rarely
successful at <28 weeks.
Moderate
Ertekin. Et al.
(2015) [125]
Hypertension—Severe
preeclampsia between 27
and 34 weeks
Prospective cohort
study
Turkey. Single centre study
from 2010 to 2012
N = 70 To compare EM (n = 33)
versus early birth (n = 37) on the
first year of neurologic
development of infants, and other
neonatal and maternal outcomes
There was no significant difference
in the first year neurological
development of infants between
the two groups. The women’s
average weeks of gestation were
31.09 ± 2.53 in the EM group and
30.64 ± 2.31 in the immediate birth
group.
Moderate
�Mashiloane
et al. (2002)
[126]
Hypertension—Severe
preeclampsia from 26 to
32 weeks
Prospective cohort
Study
South Africa. Single-centre
data from June 1999 to June
2000
N = 108 To compare outcomes
associated with planned CS
(n = 68), CS following attempted
IOL (n = 14), and vaginal birth
following successful IOL (n = 26).
Perinatal mortality was highest for
the babies delivered following IOL
(vaginal birth vs. CS after IOL,
P = 0�0004; vaginal birth vs.
planned CS, P = 0�002).
Moderate
�Nassar et al.
(1998) [132]
Hypertension—Severe
preeclampsia between 24
and 34 weeks
Case control study USA. Single-centre data from
1st January 1992 to 31
December 1996
N = 306 To determine the rate of
vaginal birth after IOL in severe
preeclampsia remote from term
and to discover potential
predictors of successful IOL. To
compare outcomes associated
with planned CS (n = 161), CS
following attempted IOL (n = 75),
and vaginal birth following
successful IOL (n = 70).
48% of patients given the chance
successfully delivered vaginally.
The median Bishop score was
significantly higher (3 vs 2, P =
.004) and the total hospital stay was
significantly shorter in the vaginal
birth after IOL than in the CS after
IOL. There were no significant
differences between the 2 groups in
gestational age at birth, birth
weight, 5-minute Apgar score, or
postpartum endometritis. Only the
Bishop score was significantly
associated with a successful IOL
(OR 1.38). Gestational age reached
marginal significance (OR 1.30).
Moderate
(Continued)
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Cruz et al.
(2012) [129]
Hypertension—
gestational
Retrospective
population based
cohort study
USA. Data from multicentre
database (from 12 clinical
centres and 19 hospitals) with
228,668 deliveries greater than
23 weeks, from between 2002
and 2008, with the majority
(87%) of births occurring from
2005 through 2007
N = 3588 Assess the optimal
timing of birth for women with
gestational hypertension by
quantifying the risks of adverse
maternal and fetal outcomes
associated with IOL at each
gestational week, from 36 to 41
completed weeks, compared with
those with ongoing pregnancy.
IOL between 38- and 39-weeks’
balances the lowest maternal and
neonatal morbidity/mortality.
After IOL, the rate of maternal
morbidity/mortality reached a
nadir of 89.9 per 1000 live births
(95% confidence interval, 68.1–
111.8) at 38–38 6/7 weeks’
gestation, although the rate of
neonatal morbidity/mortality fell
to 10.5 per 1000 live births (95%
confidence interval, 2.8–18.2) at
39–39 6/7 weeks. There were only
3 total stillbirths in the study
cohort.
Moderate
Hutcheon et al.
(2010) [128]
Hypertension—pre-
existing (gestation is
variable)
Retrospective
population based
cohort study
USA. Data from the US
National Centre for Health
Statistics’ period-linked birth
infant death and stillbirth files
from between 1995 and 2005
N = 171 669 singleton births to
women with pre-existing
(chronic) hypertension. To
determine the optimal timing of
birth by quantifying the
gestational age-specific risks of
stillbirth associated with ongoing
pregnancy and the gestational age-
specific risks of neonatal mortality
or serious neonatal morbidity
following the IOL.
IOL between 38- and 39-weeks’
balances the lowest maternal and
neonatal morbidity/mortality. The
risk of stillbirth remained stable at
1.0–1.1 per 1000 ongoing
pregnancies until 38 weeks, before
rising steadily to 3.5 per 1000 at 41
weeks. The risk of serious neonatal
morbidity/neonatal mortality
decreased sharply between 36 and
38 weeks from 137 to 26 per 1000
induced births, before stabilising
beyond 39 weeks.
Serious
Knight et al.
(2017) [172]
Maternal age Retrospective cohort
study
UK. Multi-site study with
national public hospital data
from between April 2009 and
March 2014
N = 77327 To compare outcomes
between IOL (at between 39 and
41 weeks) (n = 51,744) and EM
(n = 25,583) for nulliparous
women aged � 35. Women with
pre-existing comorbidities or
other indications for induction
were excluded.
IOL at 40 weeks was associated
with a lower risk of in-hospital
perinatal death (0.08% vs 0.26%;
RR 0.33; p = 0.015) and meconium
aspiration syndrome (0.44% vs
0.86%; RR 0.52; p = 0.002), but an
increased risk of instrumental
vaginal birth (RR 1.06; p = 0.020)
and CS (RR 1.05; p = 0.019). A
number needed to treat analysis
indicated that 562 IOL at 40 weeks
would be required to prevent one
perinatal death.
Low
Oron, Hirsch
[173]� [173]
Maternal cardiac disease Prospective cohort
study
Israel. Single centre high risk
pregnancy clinic data from
1995 to 2001.
N = 121 To examine the safety of
IOL in women with heart disease
by comparing outcomes for
women who underwent IOL
between 37 and 40 weeks (n = 47)
versus EM (n = 74)
There was no significant difference
in complication rate between the
two groups.
Moderate
Kawakita et al.
(2017) [167]
Maternal Elevated BMI Retrospective cohort
study
USA. Secondary analysis of
data from the Consortium on
Safe Labor, conducted from
2002 to 2008 in 12 clinical
centers.
N = 4349 (morbidly obese
women) To compare the CS rate
of elective IOL with EM in
morbidly obese women (�40 kg/
m2) with singleton, cephalic
gestations and no previous CS or
other comorbidity between 37 and
41+6 weeks.
In nulliparas, elective IOL was not
associated with increased risks of
CS and was associated with
decreased risks of macrosomia
(2.2% vs 11.0%) at early term (37 0/
7 to 38 6/7) and decreased NICU
admission (5.1% vs 8.9%) at full
term (39 0/7 to 40 6/7). In
multiparas, IOL was associated
with a decreased risk of
macrosomia at early term (4.2% vs
14.3%), CS at full term (5.4% vs
7.9%), and composite neonatal
outcome (0% vs 0.6%) at full term.
Low
Lee et al.
(2016) [169]
Maternal Elevated BMI Retrospective cohort
study
USA. All birth in California in
2007 using a national dataset.
N = 74,725 (obese women) To
compare outcomes between
elective IOL and EM in obese
women (�30.0 kg/m2) with
singleton pregnancies between
37–40 weeks. Women with prior
CS or chronic diseases were
excluded.
IOL was associated with lower CS
rates, and lower odds of
macrosomia. There were no
differences in the other reported
outcomes.
Low
(Continued)
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Pickens et al.
(2018) [168]
Maternal Elevated BMI Retrospective cohort
study
USA. All birth in California
between 2007 and 2011 using a
national dataset.
N = 165,975 (obese women) To
compare outcomes associated
with IOL versus EM in obese
women (�30.0 kg/m2) with
singleton pregnancies between 39
and 41 weeks. Women with prior
CS or medical comorbidities were
excluded.
IOL was associated with reduced
CS rates (at 39 weeks of gestation,
frequencies were 35.9% vs 41.0%, p
= < .05), reduced severe maternal
morbidity (5.6% vs 7.6%, p = <
.05), and reduced NICU
admissions (7.9% vs 10.1%, p = <
.05).
Low
Wolfe et al.
(2014) [170]
Maternal Elevated BMI Retrospective cohort
study
USA. Single centre study with
data from between 2007 and
2012
N = 470 To compare outcomes in
obese (�30.0 kg/m2) nulliparous
women with an unfavourable
cervix (modified Bishop
score < 5) undergoing elective
IOL between 39 and 41 weeks
(n = 60) with EM after 39 weeks
(n = 410). Women with medical
comorbidities were excluded.
IOL was associated with higher
rates of CS (40% vs 25.9%, p =
.022), and NICO admission rates
(18.3% vs 6.3%, p = .001). Other
maternal and neonatal outcomes
were similar.
Low
Cheng et al.
(2012) [176]
Macrosomia Retrospective cohort
study
USA. Analysis of national
dataset—Vital Statistics
Natality birth certificate
registry provided by the Centre
of Disease Control and
Prevention over a one year
period (2003).
N = 132,112 To compare the
frequency of CS for women who
had an IOL at 39 weeks with a
neonatal birthweight of 4000 +/-
125g (birthweight 3875-4125g)
with women who gave birth
(following IOL or spontaneous
onset of labour) at 40 weeks with
birthweight 4075–4325 g, at 41
weeks with a birthweight at 4275–
4525 g, or 42 weeks with a
birthweight of 4475–4725 g
The frequency of CS in the IOL
group was lower compared with
women who delivered at a later
gestational age (35.2% versus
40.9%; OR 1.25)
Low
Sanchez-
Ramos et al.
(2002)� [175]
Macrosomia—Suspected Systematic review and
meta-analysis. Only
observational studies
reported here as RCTs
included in Cochrane
review.
11 studies included including 2
RCTs and 9 observational
studies from the US (5),
Denmark (2) and Germany,
Israel, Italy, and Norway (1).
Studies were published
between 1966 and 2002.
N = 3751 To compare outcomes
associated with IOL (n = 2700)
versus EM (n = 1051) for
suspected macrosomia
Analysis of non-randomised
studies indicates that the risk of CS
may be increased when IOL is
undertaken. Women who
experienced spontaneous onset of
labour had a lower incidence of CS
(OR 0.39) and higher rates of
spontaneous vaginal birth (OR
2.07). No differences were found in
rates of operative vaginal deliveries,
incidence of shoulder dystocia, or
abnormal Apgar scores in the
analyses of the observational
studies.
Low
Bleicher et al.
(2017) [41]
Post-term pregnancy Retrospective cohort
study
Israel. Single centre study
comparing data between two
policy periods
N = 1930 To compare outcomes
for women who birthed under a
policy of IOL at 42 weeks
(n = 968; from2008–2009) with
those who birthed under a policy
of IOL at 41 weeks (n = 962; from
2012–2013).
Both the overall CS rate as well as
the CS rate for women who
underwent IOL was lower during
the 41-policy period than during
the 42-policy period (15% vs
19.4%, p = 0.0135 and 19% versus
27%, p = 0.0067). IOL at 41 weeks
was also associated with a
significant reduction in 1st and
2nd degree perineal lacerations
and neonatal readmission within
30 days of discharge.
Moderate
Daskalakis
et al. (2014)
[40]
Post-term pregnancy Retrospective cohort
study
Greece. Single centre study
with data from between
September 2009 and September
2011
N = 483 To compare outcomes
associated with IOL at 41+1
(n = 211) versus EM until
spontaneous onset of labour or
IOL at 42 weeks (n = 227).
Women with previous CS and
comorbidities were excluded.
No significant differences in the
two groups in terms of CS rate
(36.5% vs 34.4%) or operative
vaginal birth (11.4% vs 9.2%).
Moderate
Haq et al.
(2012) [36]
Post-term pregnancy Prospective cohort
study
Pakistan. Single centre study
with data from between 2006
and 2008.
N = 78 To compare CS rates for
IOL at 40 weeks (n = 39) versus 41
weeks (n = 39).
Less women induced at 41 weeks
had a CS compared to the 40 weeks
group (16% vs 29%, p < 0.0001).
Moderate
(Continued)
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Hermus et al.
(2009) [39]
Post-term pregnancy Retrospective matched
cohort study
Netherlands. Multi-centre
study including two hospitals,
with data from between 2002
and 2005.
N = 674 To compare outcomes for
women who underwent IOL (=
377) at 42 weeks to EM beyond 42
week (n = 377). Women with
comorbidities were excluded.
EM was associated with lower rate
of CS (12.5% vs 13.6%, RR 0.9), but
higher incidence of shoulder
dystocia (RR, 4.3) and meconium-
stained amniotic fluid (RR, 1.8).
Moderate
Kassab et al.
(2011) [38]
Post-term pregnancy Retrospective cohort
study
UK. Single centre study
comparing data between two
policy periods
N = 351 To compare outcomes
associated with a policy period of
IOL at 41+3 days (n = 124; August
2006 and March 2007) versus a
policy-period of IOL at 42 weeks
(n = 227; April 2007 and July
2008). Women with previous CS
or comorbidities were excluded.
The CS rate was higher under the
earlier IOL policy (p = 0.04) for
nulliparous women only. The
average delay in birth was >2 days.
The study was not powered to
examine neonatal outcomes.
Moderate
Mahomed
et al. (2016)
[37]
Post-term pregnancy Retrospective cohort
study
Australia. Multisite data from
Queensland Perinatal Data
Collection Unit. All births in
Qld that meet inclusion criteria
between January 2005 and
December 2012
N = 7,811 To compare CS rates
associated with IOL at 40–40+6
weeks (n = 2153) versus
spontaneous birth at 41–41+6
weeks (n = 5658)
CS rates were significantly higher
in the IOL group (OR 1.52; 21%
versus 14.9%).
Moderate
McCoy et al.
(2018) [47]
Post-term pregnancy Secondary analysis of
prospective cohort
study
USA. Single centre study with
data from between May 2013 to
June 2015
N = 854 To compare outcomes
associated with IOL at term (37–
40+6) (n = 700) versus IOL at >41
weeks (n = 154) among women
with an unfavourable cervix
(Bishop score of <6 and cervical
dilation <2 cm). Women who had
had a previous CS or
contraindication to vaginal birth
excluded.
Women induced at >41 weeks had
an increased risk of CS versus
those induced at term (46.8 versus
26.0%, p < .001).
Moderate
Mya et al.
(2017) [46]
Post-term pregnancy Secondary analysis two
WHO multi-country
surveys between 2004–
2008
A secondary analysis of the
WHO Global Survey
(WHOGS) and the WHO
Multi-country Survey
(WHOMCS) conducted in
Africa, Asia, Latin America and
the Middle East, from 292
facilities in 21 countries.
N = 31,052 To assess outcomes of
IOL (n = 4,332) in comparison to
EM (n = 26,720) at and beyond 41
weeks. Only women with low risk
singleton pregnancies at �41
completed weeks were included.
Compared to IOL, EM was
significantly associated with
decreased risk of CS in both
databases (OR 0.70 and IOR 0.67).
The choice between IOL and EM
should be cautiously considered
since the available evidences are
still quite limited.
Low
Pavicic et al.
(2009) [42]
Post-term pregnancy Retrospective cohort
study
Canada. Single centre study
with data from 2005 to 2007
N = 1367 To compare outcomes
associated with IOL at 41+1
(n = 722) versus EM until
spontaneous onset of labour or
IOL at 42 weeks (n = 645).
Exclusion criteria not mentioned.
IOL was significantly associated
with increased risk of CS (25.4% vs
16.6%, p = 0.001).
Serious
Teo and
Kumar (2017)
[43]
Post-term pregnancy Retrospective cohort
study
Australia. Single centre study
with data from 2007 to 2013
N = 6501 To compare outcomes
associated with IOL at 41+1
(n = 3588) versus EM (n = 2913).
Women with commodities were
not excluded, and women in the
IOL were more likely to be obese
or hypertensive.
IOL was associated with higher
rates of CS (29.4% vs 18.5%,
p = 0.001) and instrumental birth
(20.2% vs 17.7%, p = 0.012)
Serious
Thangarajah
et al. (2016)
[44]
Post-term pregnancy Retrospective cohort
study
Germany. Singe centre study
with data from between 2000–
2014
N = 856 To compare outcomes
associated with IOL at 41+1
(n = 400) versus EM (n = 456).
Women with previous CS or
comorbidities were excluded.
IOL was associated with increased
rates of CS (33.8% vs. 21.1%,
p < 0.001), and perineal
lacerations (38.1% vs 26.4%,
p = 0.002).
Moderate
Wolff et al.
(2016) [45]
Post-term pregnancy Retrospective cohort
study
Denmark. Multi-site study
including 24 centres between
2009–2012.
N = 36,837 To compare outcomes
for women who birthed under a
policy of IOL at 41+2 weeks
(2012) (n = 8545) versus those
who birthed prior to the
introduction of this policy and
birthed under a policy of IOL at
42 weeks (2010) (n = 9713).
Women with comorbidities were
excluded.
The number of IOL within the
study population doubled after
implementation of the new
guideline. There was a significant
reduction in CS rates between 2010
and 2012 (p = 0.05), and a non-
significant reduction in perinatal
mortality of 60% (from 10 to 3).
There were no significant
differences in instrumental
deliveries or perinatal outcomes.
Moderate
(Continued)
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Table 2. (Continued)
Author,
Publication
year
Indication Study design Country and Setting Aim and Participants Main Findings Risk of
bias
Omole-Ohonsi
et al. (2009)
[83]
PROM, at term Prospective cohort
study
Nigeria. Single centre data with
data collection commenced in
2004 (end date not stated)
N = 200 To compare immediate
IOL (N = 100) with delayed IOL
after EM for 12 hours (N = 100)
for women with PROM � 37
weeks and no contraindication to
IOL or vaginal birth.
33% of the women in the delayed
IOL group went into spontaneous
labour. Immediate IOL was
associate with significantly lower
rates of CS (OR = 0.18), and
operative vaginal birth
(OR = 0.26), and higher rates of
vaginal birth (OR = 6.10). There
was no significant difference in the
neonatal outcomes.
Low
Pintucci et al.
(2014) [85]
PROM, at term Retrospective cohort
study
Italy. Single centre data from
between January 2006 and
December 2008
N = 1315 To analyse outcomes
associated with a policy of delayed
IOL after EM for 48 hours for
women with PROM � 37 weeks
and no other obstetric risk factors.
84% of the women went into
spontaneous labour within 48
hours. There were very low rate of
clinical chorioamnionitis (2.3%)
and neonatal infection rate (2.8%).
The overall CS rate was 4.5%,
which was lower for women who
went into labour spontaneously
than those who underwent IOL
(OR = 1.76).
Moderate
Sadeh-
Mestechkin
et al. (2016)
[84]
PROM, at term Retrospective cohort
study
Setting not specified. Single
centre data from March 2013
to April 2014
N = 325 To compared immediate
IOL (N = 213) versus delayed IOL
after EM for 48 hours (N = 112)
for women with PROM � 37
weeks
The delayed group had
significantly higher rate of
prolonged hospitalisation
(p = 0.043), and higher rates of CS
(16.4% vs 7.1%, p = 0.024). There
was no significant difference in
chorioamnionitis, postpartum
endometritis, and there were no
cases of early neonatal sepsis.
Moderate
Brzezinski-
Sinai et al.
(2018) [187]
Suspected fetal
compromise,
oligohydramnios
Retrospective cohort
study
Israel. Single centre study with
data between 1991–2011
N = 144 To compare outcomes for
women with isolated
oligohydramnios between 34 and
36.6 weeks who laboured
spontenaousely (n = 33) versus
those who underwent IOL
(n = 111). Included all singleton
pregnancies diagnosed with
isolated oligohydramnios
following a definition of amniotic
fluid index [AFI]<5 cm. Excluded
pregnancies with other
complications.
Spontaneous labour was associated
with statistically significant higher
rates of CS (p < .001), as well as
higher rates of maternal infection,
chorioamnionitis, and transitory
tachypnoea of the newborn. The
study concludes that IOL may be
beneficial to both the neonate and
the mother.
Moderate
Rabinovich
et al. (2018)
[188]
Suspected fetal
compromise,
intrauterine growth
restriction
Retrospective cohort
study
Israel. Single centre study. N = 2232 To compare outcomes
for IOL (n = 1428) versus EM
(n = 804) for IUGR between 34
and 38 weeks
IOL was associated with lower
stillbirth and neonatal death rates
(p < .001), higher 1 and 5 min
Apgar scores and a higher vaginal
birth rate. IOL at 37 weeks
protected from stillbirth but not
from adverse composite neonatal
outcomes.
Moderate
de Castro et al.
(2016) [158]
Twin pregnancy Retrospective cohort
study
Israel. Single centre study with
data from between 2004 and
2011
N = 883 To determine the success
rate of a trial of labour in twin
pregnancies, and identify factors
that may affect the chances of
success by comparing outcomes
for IOL (n = 287; 188 (non-Foley)
+ 99 (Foley) with spontaneous
vaginal birth for both twins
(N = 530), a CS (N = 51) or a
vaginal birth for first twin and CS
for 2nd twin (N = 15). All twin
pregnancies, first twin cephalic
who had not had a previous CS
were included.
IOL significantly decreased the
chance for achieving vaginal birth
(Foley catheter induction 74.7%;
non-Foley induction 86.7%; no
induction 88.9%, P < 0.001). No
significant difference in terms of
5-minute Apgar score in trial of
labour versus CS group.
Serious
(Continued)
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n = 277 in the EM group), Daskalakis et al. [40] found no significant differences in CS rate
(36.5% vs 34.4%) or operative vaginal births (11.4% vs 9.2%) between the two groups, the
other studies found that IOL was associated with increased risk of CS. A study by Thangarajah
et al. [44], included 856 women (n = 400 in the IOL group; n = 456 in the EM group) and
found that IOL was associated with increased rates of CS (33.8% vs. 21.1%, p< 0.001), and
perineal lacerations (38.1% vs 26.4%, p = 0.002). Similarly, a study by Pavicic [42] including
1367 women (n = 722 in the IOL group; n = 645 in the EM group) found that IOL was associ-
ated with increased CS rates (25.4% vs 16.6%, p = 0.001) and a study by Teo [43] including
6501 women (n = 3588 in the IOL group; n = 2913 in the EM group) found that IOL was asso-
ciated with higher rates of CS (29.4% vs 18.5%, p = 0.001) and instrumental birth (20.2% vs
17.7%, p = 0.012). The two latter studies were rated as having serious risk of bias as the IOL
groups included a significantly higher proportion of women with comorbidities, which were
not controlled for.
Lastly, Hermus et al. [39] conducted a retrospective matched cohort study (1:1 ratios for
both age and parity) to compare outcomes for women who underwent IOL (= 377) at 42
weeks to EM beyond 42 weeks (n = 377). This study found that EM was associated with non-
significantly lower rate of CS (12.5% vs 13.6%, RR 0.9, 95% CI 0.6 to 1.4), but higher incidence
of shoulder dystocia (RR 4.3, 95% CI 1.3 to 15) and meconium-stained amniotic fluid (RR 1.8,
95% CI 1.4 to 2.3).
Summary statement. Women having IOL beyond 41–42 weeks is associated with fewer
perinatal deaths and reduced CS rates, even though the number needed to treat to prevent
perinatal mortality is high (approx. 450).
Table 2. (Continued)
Author,
Publication
year
Indication Study design Country and Setting Aim and Participants Main Findings Risk of
bias
Hamou et al.
(2016) [159]
Twin pregnancy Retrospective cohort
study
Israel. Single centre hospital
data over a 20 year period
N = 4605 To determine the
efficacy of IOL for twin pregnancy
by comparing outcomes for
women who had an IOL (n = 653);
spontaneous birth (n = 2937)
versus elective CS (n = 1015). All
twin gestation who delivered after
24 complete gestation weeks were
included. 25% of spontaneous
twin births occurred in early
preterm, < 34 weeks.
IOL was associated with a lower
rate of CS than those who come
with spontaneous labour (77%
reduction, OR 0.23). This study
also found that the IOL was
associated with lower rates of
neonatal death (78% reduction, OR
0.22). The rate of vaginal birth in
the IOL group was 81%.
Serious
Jonsson (2015)
[157]
Twin pregnancy Retrospective cohort
study
Sweden. Medical records from
two university hospitals from
2004–2013 in Uppsala and
1994–2013 in O¨rebro.
N = 462 To investigate the
association between IOL and CS
in twin pregnancies �34 weeks by
comparing CS rates for women
who received IOL (n = 220) with
those who had spontaneous onset
of labour (n = 242). Women with
a history of previous CS were
excluded.
IOL increases the risk of CS
compared with spontaneous labour
onset (21% versus 12%), especially
if Foley catheter or prostaglandins
are required. However,
approximately 80% of induced
labours were delivered vaginally.
There were no differences in Apgar
scores
Low
Tavares et al.
(2017) [160]
Twin pregnancy Retrospective cohort
study
Portugal. Data from single
centre database with 288 twin
pregnancies between January
2007 and December 2011.
N = 75 To compare outcomes for
IOL (n = 33) versus spontaneous
vaginal birth (n = 44) in
uncomplicated twin pregnancy
after 36 weeks of gestation.
This study found no statistical
differences between the two groups
in terms of maternal and neonatal
morbidity, and admission to the
NICU. There was an increased
incidence of CS after IOL (60.6 vs.
33.3%, p < .05).
Low
�included in review by Mozurkewich, Chilimigras (10).
EM = expectant management; IOL = Induction of labour; CS = Caesarean section; GDM = Gestational diabetes mellitus; NICU = neonatal intensive care unit
https://doi.org/10.1371/journal.pone.0228196.t002
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Premature rupture of membranes (PROM)
Five studies in relation to PROM were included, consisting of two Cochrane reviews [81, 82],
one prospective cohort study [83], and two retrospective cohort studies [84, 85]. One
Cochrane review and three studies addressed PROM at term (37–42 weeks) [81, 83–85], whilst
the other Cochrane review addressed preterm PROM (<37 weeks) [82].
In relation to preterm PROM (< 37 weeks), the Cochrane review by Bond et al. [82] com-
pared outcomes associated with women undergoing a planned early birth (by IOL or CS) with
EM between 24 and 37 weeks. The review identified 12 RCTs, with 3617 women [7, 86–96]. In
terms of neonatal outcomes, this review identified no clear differences in neonatal sepsis (RR
0.93), neonatal infection (RR 1.24, 95% CI 0.66 to 1.30), and overall perinatal mortality (RR
1.76, 95% CI 0.89 to 3.50), but found that early birth was associated with a higher rate of neo-
natal death (RR 2.55, 95% CI 1.17 to 5.56), respiratory distress syndrome (RR 1.26, 5% CI 1.05
to 1.53), need for ventilation (RR 1.27, 95% CI 1.02 to 1.58), and NICU admission (RR 1.16,
95% CI 1.08 to 1.24). In terms of maternal outcomes, early birth was associated with an
increased rate of CS (RR 1.26, 95% CI 1.11 to 1.44) and endometritis (RR 1.61, 95% CI 1.00 to
2.59), and reduced rate of chorioamnionitis (RR 0.50, 95% CI 0.26 to 0.95). This review con-
ducted a subgroup analysis by gestational age, and compared outcomes associated with
planned birth <34 weeks and >34 weeks. The test for subgroup differences were not signifi-
cant for neonatal infection, respiratory distress syndrome, CS, and chorioamnionitis. There
was a decrease in endometritis in women randomised to early birth after 34 weeks [82]. The
included studies were at low or unclear risk of bias, with the overall quality of evidence rated as
moderate to high.
In relation to PROM at term (�37 weeks), the Cochrane review by Middleton et al. [81]
compared planned early birth (immediate IOL or within 24 hours) with EM (no planned inter-
vention within 24 hours). The review identified 23 RCTs, involving 8615 women [97–117].
Early birth was associated with a reduced risk of maternal infectious morbidity (chorioamnio-
nitis and/or endometritis) (RR 0.49, 95% CI 0.33 to 0.72), and neonates were less likely to have
early-onset neonatal sepsis (RR 0.73, 95% CI 0.58 to 0.92). No clear differences were seen in CS
rates (RR 0.84, 95% CI 0.69 to 1.04; 23); serious maternal morbidity or mortality (no events);
definite early-onset neonatal sepsis (RR 0.57, 95% CI 0.24 to 1.33); or perinatal mortality (RR
0.47, 95% CI 0.13 to 1.66). The quality of included studies was low; only three of the included
RCTs were of low risk of bias, while the remaining were of unclear or high risk of bias.
The remaining studies were cohort studies, assessed as of low to moderate risk of bias. A
prospective cohort study by Omole-Ohonsi et al. [83] compared immediate IOL (N = 100)
with delayed IOL after EM of 12 hours (N = 100). One-third in the delayed IOL group went
into spontaneous labour before IOL. Immediate IOL was associated with significantly lower
rates of CS (OR 0.18, 95% CI 0.07 to 0.47), operative vaginal birth (OR 0.26, 95% CI 0.07 to
0.88), and higher rates of vaginal birth (OR 6.10, 95% CI 2.76 to 13.75). There was no signifi-
cant difference in neonatal outcomes.
A retrospective cohort study by Sadeh-Mestechkin et al. [84] compared immediate IOL
(N = 213) versus delayed IOL after EM for 48 hours (N = 112). The delayed group had signifi-
cantly higher rate of prolonged hospitalisation (p = 0.043) (as an indicator for maternal com-
plications), and higher rates of CS (16.4% vs 7.1%, p = 0.024). There was no significant
difference in the rate of clinical chorioamnionitis or postpartum endometritis, and there were
no cases of early neonatal sepsis. A retrospective cohort study by Pintucci et al. [85] analysed
outcomes associated with a policy of delayed IOL after EM for 48 hours (N = 1315). In total,
84% of the women went into spontaneous labour within 48 hours. There were low rates of clin-
ical chorioamnionitis (2.3%) and neonatal infection rate (2.8%). The overall CS rate was 4.5%,
Indications for induction of labour
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which was lower for women who went into labour spontaneously than those who underwent
IOL (OR 1.76, 95% CI 1.03 to 3.02).
Summary statement. Early birth for PROM at term may help reduce maternal and neo-
natal infections without increasing CS rates.
Early birth for pre-term PROM increases the risk of infant death after birth, respiratory
problems and NICU admissions, and CS rates, and is associated with a decreased incidence of
chorioamnionitis.
Hypertension/preeclampsia
Fifteen studies in relation to preeclampsia, chronic or gestational hypertension were included.
There were three Cochrane reviews [118–120], two RCTs [121, 122], a post hoc analysis of an
RCT [123], three prospective cohort studies [124–126], four retrospective cohort studies [127–
130], and two case control studies [131, 132]. A further systematic review was excluded as it
did not identify any additional studies not already included [133]. The majority of studies
focussed on severe preeclampsia as an indicator for IOL, with most of these in women giving
birth<34 weeks gestation [119–121, 124–127, 130–132]. One study pertained to gestational
hypertension [129], one to chronic hypertension [128], one to late preterm preeclampsia (34–
36+6 weeks gestation) [122] and two studies included multiple hypertensive disorders as one
group [118, 123].
In relation to hypertensive disorders broadly, Cluver et al. [118] conducted a Cochrane
review comparing planned early birth versus EM from 34 weeks to term. The review identified
five RCTs, with a total of 1819 women [134–138]. Both the HYPITAT-I (Hypertension and Pre-
eclampsia Intervention Trial at Term) and HYPITAT-II trials were included [134, 135]. The
HYPITAT-I trial compared IOL at 36–41 weeks (within 24 hours of randomisation) to EM
until spontaneous onset of labour for pregnant women with mild to moderate gestational
hypertension or mild preeclampsia [135]. The HYPITAT-II trial compared IOL at 34–36+6
weeks to EM until 37 weeks for pregnant women with gestational hypertension, mild pre-
eclampsia, or deteriorating chronic hypertension [134]. Three further RCTs compared planned
early birth via IOL or CS versus EM for pregnant women with mild preeclampsia or gestational
hypertension [136, 138] or moderate essential chronic hypertension [137]. The review found a
lower risk of composite maternal mortality and severe morbidity for women randomised to
receive planned early birth. There was not enough information to draw conclusions about the
effects on composite infant mortality and severe morbidity, with contrasting findings in HYPI-
TAT-I (IOL from 36 weeks with RR 0.75, 95% CI 0.46 to 1.28 for composite infant outcome)
[135] versus HYPITAT- II (IOL from 34 to 36+6 weeks, RR 1.4 95% CI 1.1 to 1.7 for any neona-
tal morbidity) [134]. Planned early birth was associated with higher levels of respiratory distress
syndrome (RR 2.24, 95% CI 1.20 to 4.18), and NICU admissions (RR 1.65, 95% CI 1.13 to 2.40),
with this finding driven by higher neonatal risks in the earlier planned birth group of HYPITAT
II [134]. There was no clear difference between the groups for CS or length of hospital stay.
Tajik et al. [123] conducted a post hoc analysis of the HYPITAT-I trial to assess whether
cervical ripeness should play a role in the decision for IOL for women with gestational hyper-
tension or mild preeclampsia at term. This trial included a total of 756 women, with 377 in the
IOL group, and 379 in the EM group (spontaneous labour). This study found that the superi-
ority of IOL varied significantly according to cervical favourability. The length of the woman’s
cervix was a predictor of outcome. For women who were managed expectantly, the longer the
cervix, the higher the risk of maternal complications, whereas in women who were induced,
cervical length was not associated with increased maternal complications. Similarly, IOL was
more likely to reduce the CS rate in women with an unfavourable cervix.
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Finally, two retrospective cohort studies sought to determine the optimal timing of birth for
women with gestational hypertension [129] and chronic hypertension [128]. Both studies
found that IOL between 38- and 39 weeks balances the lowest maternal and neonatal morbid-
ity/mortality for both women with gestational hypertension [129] and those with chronic
hypertension [128].
In relation to severe preeclampsia, the majority of included studies assessed outcomes
remote from term, i.e. during the very preterm period of less than 34 weeks. Only one study
focussed on late preterm preeclampsia (34–36+6 weeks gestation) [122]. An RCT by Chappell
et al. (2019) compared planned birth (usually IOL) (n = 448) versus EM (n = 338) in women
with late preterm pre-eclampsia from 34 to 37 weeks (The PHOENIX trial) [122]. This study
found that planned birth reduced maternal morbidity and severe hypertension (65% vs 75%,
RR = 0.86, 95% CI 0�79–0�94; p = 0�0005), but resulted in more neonatal admissions for pre-
maturity (42% vs 34%, RR 1�26, 1�08–1�47; p = 0�0034).
In relation to preeclampsia remote from terms (<34 weeks), a Cochrane review by Chur-
chill et al. [119] compared planned early birth versus EM for severe preeclampsia between 24–
34 weeks’ gestation. The review included four RCTs, with a total of 425 women [139–142]. The
study found that an expectant approach may be associated with decreased morbidity for the
baby. Babies whose mothers were allocated to the early birth group had more intraventricular
haemorrhage (RR 1.82, 95%CI 1.06 to 3.14), more hyaline membrane disease (RR 2.30, 95%
CI 1.39 to 3.81), required more ventilation (RR 1.50, 95% CI 1.11 to 2.02), were more likely to
have a lower gestation at birth, more likely to be admitted to neonatal intensive care (RR 1.35,
95% CI 1.16 to 1.58) and have a longer stay in the NICU, but less likely to be small-for-gesta-
tional age (RR 0.30, 95% CI 0.14 to 0.65). There was insufficient data for reliable conclusions
on most outcomes for the mother, except that women allocated to the early birth group were
more likely to have a CS (RR 1.09, 95% CI 1.01 to 1.18). There was also a second systematic
review and meta-analysis of RCTs by Wang et al. [143] which largely included the same studies
as the Cochrane review [119], with an additional two studies: the MEXPRE trial [121] and a
trial by Duvekot et al. [144]. The latter was closed after 24 months because of low recruitment
and the findings were reported by abstract only, and as such is excluded from our review. As
the only additional study identified by this review is the MEXPRE trial [121], we have excluded
the review by Wang et al. [143] and we report on the MEXPRE trial here.
The MEXPRE trial included 267 women and sought to determine whether EM in women
with severe preeclampsia prior to 34 weeks results in improved neonatal outcome in countries
with limited resources (i.e. low-middle income countries in Latin America) [121]. This study
found no difference in the rate of perinatal mortality (9.4% vs 8.7%; RR 0.91, 95% CI 0.34 to
1.93), composite of neonatal morbidities (56.4% vs 55.6%; RR 1.01, 95% CI 0.81 to 1.26), or
maternal morbidity (25.2% vs 20.3%; RR 1.24, 95% CI 0.79 to 1.94) with EM versus early birth.
Small for gestational age (21.7% vs 9.4%; RR 2.27, 95% CI 1.21 to 4.14) and placental abruption
were more common with EM (RR 5.07, 95% CI 1.13 to 22.7).
Four cohort studies [125–127, 130] and two case control studies [131, 132] assessed the
association between mode of birth and maternal and neonatal outcomes for severe preeclamp-
sia remote from term. A prospective cohort study by Ertekin [125] that compared EM (n = 33)
versus early birth by IOL or CS (n = 37) for severe preterm preeclampsia on a range of mater-
nal and neonatal outcomes, including the first year of neurological development of infant, did
not find statistically significant differences between the two groups. However, there were seven
fetal deaths in the immediate birth group versus two in the EM group (P = 0.058). This was
most likely due to women with more significant risk factors (e.g. HELLP syndrome) being
assigned to the immediate birth group.
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The remaining studies addressed the safety of women undergoing an IOL versus a CS for
severe preeclampsia remote from term. With the exception of one study [126], these concluded
that IOL is a reasonable option that was not associated with poorer maternal and neonatal
outcomes [127, 130–132]. A retrospective cohort study by Alanis at al. [127] assessed differ-
ences in neonatal outcomes with IOL (n = 282) versus planned CS (n = 209) in women with
early onset severe preeclampsia and found that IOL was not associated with an increase in
neonatal morbidity or mortality even after controlling for gestational age and other confound-
ers. Similarly, Alexander et al. [130] conducted a retrospective cohort study comparing IOL
(n = 145) with planned CS (n = 133) on neonatal outcomes in women whose pregnancies were
complicated by preterm severe preeclampsia and birth of very low birth-weight infants. This
study found that IOL in cases of severe preeclampsia was not harmful to very low birth-weight
infants. While Apgar scores of�3 at 5 minutes were more likely in the IOL group (6% versus
2%, P = 0.04), other neonatal outcomes, including respiratory distress syndrome, grade 3 or 4
intraventricular haemorrhage, sepsis, seizures, and neonatal death, were similar in the two
groups. Vaginal birth was accomplished by 50 (34%) women in the IOL group.
The two included case control studies had similar findings, and also indicated that IOL for
severe preeclampsia should be considered as a reasonable option remote from term rather
than a CS [131, 132]. Both studies conducted retrospective chart reviews to determine the rate
of vaginal birth after IOL in severe preeclampsia remote from term to identify factors associ-
ated with its success and evaluate neonatal outcomes based on induction outcome. Based on a
sample of 306 women, Nassar et al. [132] found that of the women that were induced, 48%
gave birth vaginally. The Bishop score on admission was the best predictor of success, although
the chance of successful IOL increased with advancing gestational age (ranging from 31.6% at
</ = 28 weeks’ gestation to 62.5% at>32 weeks’ gestation). Based on a sample of 250 women,
Blackwell et al. [131] found that attempted IOL did not increase neonatal morbidity, and that
IOL success was significantly associated with gestational age (rarely successful at<28 weeks).
The only study that presented different findings was a prospective cohort study by Mashiloane
et al. [126] that compared outcomes associated with planned CS (n = 68), CS following
attempted IOL (n = 14), and vaginal birth following successful IOL (n = 26) for severe pre-
eclampsia from 26–32 weeks. This study found that perinatal mortality was significantly higher
following IOL (p = 0.0004), and that planned CS contributed to a better perinatal outcome
than vaginal birth.
We also identified two other studies in relation to preeclampsia in broader terms, not
specified as remote from term. A prospective cohort study by Amorim et al. [124] evaluated
the association between mode of birth (vaginal versus CS) and maternal outcomes for 500
women with severe preeclampsia. This study found that the risk of severe maternal morbidity
was significantly greater in women in the CS group (54.0% versus 32.7%) irrespective of the
presence of labour. Severe maternal morbidity was found to be associated with CS (OR 1.91).
Amorim et al. [120] also conducted a Cochrane review to compare maternal and neonatal
outcomes for women with severe preeclampsia who had a planned CS versus planned vaginal
birth. However, this review did not identify any studies for inclusion and had no results to
report.
Summary statement. RCT evidence suggests decreased maternal morbidity after IOL for
preeclampsia from 34 weeks gestation, however at the cost of increased neonatal morbidity if
undertaken at 34–37 weeks. There is little agreement on the timing of birth for women with
chronic hypertension or gestational hypertension at term, but there is some evidence that indi-
cates that planned birth between 38 and 39 weeks is associated with the lowest maternal and
neonatal morbidity/mortality. EM for severe preeclampsia remote from term increases birth-
weight and reduces neonatal morbidity.
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Diabetes
Nine studies in relation to diabetes were included, consisting of two Cochrane reviews [9, 145],
a secondary analysis of a trial that compared different treatments for mild gestational diabetes
mellitus (GDM) [146] and six retrospective cohort studies [147–152]. With the exception of
one study [145], all evaluated women with GDM, and excluded those with type I or II diabetes.
The Cochrane review by Bouvain et al. [145] included one RCT that compared outcomes
for IOL�38 weeks (n = 100) versus EM (until 42 weeks) (n = 100) for pregnant women with
diabetes (either type I or type II, or GDM) treated with insulin [153]. Of the 200 participants,
187 women had GDM and 13 had type 2 diabetes. This study found no significant difference
between the two groups in terms of CS (RR 0.81, 95% CI 0.52 to 1.26). The risk of macrosomia
was reduced in the IOL group (RR 0.56, 95% CI 0.32 to 0.98) and three cases of mild shoulder
dystocia were reported in the EM group. No other types of perinatal morbidity were reported.
The Cochrane review by Biesty et al. [9] assessed the effect of planned birth for women with
gestational diabetes and included one RCT, the GINEXMAL trial [154]. This trial included
425 women with GDM at term, randomised to IOL (between 38 and 39 weeks) (n = 214) or
EM (n = 211) (until 41 weeks). This study found no difference between the two groups in
terms of CS rates (RR 1.06, 95% CI 0.64 to 1.77; 12.6% in the IOL group versus 11.7% in the
expectant group), or other maternal or neonatal outcomes. There were no maternal or fetal
deaths. The study was underpowered and any reported differences between the two groups
were very small and not clinically relevant.
There were four retrospective cohort studies that compared outcomes for women with
GDM who underwent IOL versus EM, with CS rates as a primary outcome [147, 149–151]. A
retrospective cohort study by Bettikher et al. [147] that compared outcomes for IOL (gestation
not stated) in 43 women with EM until spontaneous labour in 188 women, found no signifi-
cant difference between the two groups in terms of CS rate, or any of the other maternal or
neonatal outcomes assessed (i.e. the frequency of uterine inertia, uncoordinated contractions
and fetal distress). This study concluded that, in the absence of signs of fetal distress or macro-
somia, planned early birth was not indicated. Similarly, Grabowska et al. [149] compared CS
rates for 96 women who underwent IOL with 32 women who had a spontaneous labour and
found that IOL did not increase the risk of CS (25% versus 25%, p = 0.66). A cohort study by
Melamed [150] compared outcomes associated with IOL at 38 or 39 weeks and EM for 6417
women with GDM, and found that IOL at 38 or 39 weeks was associated with a lower CS rates
but higher risk of NICU admission, when done at<39 weeks gestation.
Four studies assessed the impact of different timings of IOL for women with GDM in terms
of CS rates [146, 148] or maternal and neonatal outcomes [151, 152]. A retrospective cohort
study by Hochberg et al. (2019) compared outcomes for IOL at 37+0 and 38 + 6 weeks
(n = 193) versus 39+0 and 40+6 weeks (n = 237) and found that the rates of composite mater-
nal outcome and composite neonatal outcome did not differ between groups [152]. A retro-
spective cohort study by Vitner et al. (2019) found that IOL was associated with increased risk
for adverse composite neonatal outcome or NICU admission when done prior to 39 weeks
[151].
Specific to CS rates, Sutton et al. [146] conducted a secondary analysis of a trial investigat-
ing different treatments for mild GDM [155] to compare the rates of CS associated with IOL
(n = 220) versus EM (n = 459) at different gestational ages. This study found that IOL was not
associated with increased rates of CS at 37, 38, or 39 weeks, but was associated with a 3-fold
increase in CS rates at 40 weeks and beyond. A retrospective cohort study by Feghali et al.
[148] compared CS rates in women undergoing IOL at each week of gestation, with EM to a
later gestational age. Similarly, IOL at 37 weeks, 38 weeks and 39 weeks was associated with
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similar rates of CS than EM, particularly for nulliparous women. The difference in CS rates
between the two groups was only significant at 38 weeks for multiparous women. This study
did not report on outcomes at 40+ weeks. The included cohort studies were all rated as having
a moderate to serious risk of bias, as the reason for IOL was not clearly defined, therefore find-
ings need to be interpreted with caution.
Summary statement. There was little quality evidence to inform management between
IOL at term or EM for women with diabetes during pregnancy, and the little evidence that was
available was largely limited to GDM. Only one relevant study included women with pre-exist-
ing diabetes (Type I and Type 2), consisting of only 13 women.
Twin pregnancy
We identified five studies in relation to twin pregnancy, consisting of a Cochrane review [156],
and four retrospective cohort studies [157–160]. None of the included studies conducted an
analysis by chorionicity. Chorionicity data was unavailable or incomplete in three studies [156,
158, 159], and two studies had the data but did not perform this sub-analysis [157, 160].
The Cochrane review [156] compared elective birth from 37 weeks to EM for women with
an otherwise uncomplicated twin pregnancy. This review identified two RCTs for inclusion,
involving a total of 271 women and 542 infants [156, 161]. Women in the elective birth group
(n = 133) had a planned birth at 37 weeks by either CS or IOL in one of the included studies
[162], and by IOL in the other study [161]. Women randomised to the EM group (n = 138)
had their care according to local hospital guidelines, which involved either awaiting the
spontaneous onset of labour, or having a planned birth after 38 weeks. The review found no
statistically significant differences in risk of CS, perinatal death or serious infant morbidity, or
maternal death or serious maternal morbidity, although both perinatal (RR 0.34, 95%CI 0.01
to 8.35) and maternal composite morbidity and mortality (RR 0.29, 95% CI 0.06 to 1.38) were
lower (albeit not statistically) in the elective birth group.
A retrospective cohort study by Tavares et al. [160] compared outcomes for IOL versus
spontaneous vaginal birth in twin pregnancy after 36 weeks of gestation. Of the 288 women
with multiple pregnancies during the study period, 75 twin pregnancies >36 weeks of gesta-
tion were included, with 33 women undergoing IOL and 42 women who went into labour
spontaneously. This study found no statistical differences between the two groups in terms
of maternal and neonatal morbidity, or admission to the NICU, but did find a significant
increase in CS in the IOL group (60.6 vs. 33.3%, p<0.05).
The remaining cohort studies examined birth outcomes in twin pregnancies. A study by
de Castro et al. [158] measured twin pregnancy labour outcomes, with a subgroup comparison
for women who underwent IOL (n = 287) with women who had a spontaneous vaginal birth
for both twins, a CS or a vaginal birth for first twin and CS for 2nd twin (n = 596). This study
found that IOL significantly reduced the chance of achieving vaginal birth (Foley catheter
induction 74.7%; non-Foley induction 86.7%; no induction 88.9%, p< 0.001). Similarly, Jons-
son [157] retrospectively compared outcomes for women who underwent IOL (n = 220) with
those who had a spontaneous labour (n = 242), and found that IOL in twin pregnancies
increased the risk of CS compared with spontaneous labour onset, especially if Foley catheters
or prostaglandins were used. However, approximately 80% of babies born from women who
had an IOL were born vaginally. These findings are not supported by Hamou et al. [159]
which compared outcomes for women who had an IOL (n = 653); spontaneous birth
(n = 2937) versus elective CS (n = 1015). While consistently this study found that the rate of
vaginal birth in the IOL group was 81%, IOL was found to be associated with a lower rate of
CS than spontaneous labour (77% reduction, OR 0.23) and lower rates of neonatal death (78%
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reduction, OR 0.22). However, this study was assessed as of serious risk of bias, and the high
adverse outcome observed in the spontaneous twin group is likely because a large proportion
of them (25%) were early preterm, prior to 34 weeks.
Summary statement. While some cohort studies found that IOL in twin pregnancies
increases the risk of CS compared to spontaneous labour onset, other studies found the
reverse. Evidence from two RCTs (included in a Cochrane review) found non-significant
improvements in composite neonatal and maternal outcomes with planned birth for twins at
37 week.
Intrahepatic cholestasis of pregnancy
In relation to intrahepatic cholestasis of pregnancy (ICP), we identified three studies, consist-
ing of a Cochrane review [163] and two retrospective cohort studies [164, 165]. The Cochrane
review [163] evaluated the effectiveness and safety of interventions in women with cholestasis
of pregnancy. While this review identified 21 RCTs, only one included RCT, the PITCH trial,
compared outcomes for early term birth to EM (and as such is the only RCT relevant here)
[166]. The PITCH trial included 63 women, 30 of which were randomised to IOL between
37– 37+6 weeks and 33 randomised to EM (spontaneous labour until 40 weeks or CS under-
taken by normal obstetric guidelines, usually after 39 weeks). There were no stillbirths or
neonatal deaths in either group and no significant differences in CS (RR 0.68), passage of
meconium-stained liquor (RR 0.55, 95% CI 0.15 to 2.01) or admission to NICU (RR 0.55,
95% CI 0.05 to 5.76). This study was underpowered to detect other clinically important differ-
ences. Subgroup analysis results by bile acid level were not reported.
The retrospective cohort study by Kohari et al. [165] sought to determine the efficacy of a
planned early birth policy for women with severe ICP (bile acids >40μmol/L) by comparing
outcomes for women who gave birth under an active management policy (between 2009–
2013) to those who were cared for prior to the introduction of this policy (between 2005–
2008). Women with ICP who gave birth under the active management policy (n = 128) were
managed as inpatients and had a planned birth between 36 and 37 weeks. Prior to the intro-
duction of this policy, decisions around mode and timing of birth were made at the discretion
of the health professional. The active management policy was found to be associated with a sig-
nificant reduction in the incidence of stillbirth (0% versus 3.4%, p = 0.035). There was no dif-
ference in CS rates or NICU admissions. Women’s demographic characteristics were similar
between the groups, with the exception of greater maternal age and GDM in the newer cohort.
A retrospective cohort study by Puljic et al. [164] sought to determine the optimal timing of
birth for pregnancies complicated by ICP (no stratification by bile acid level), by comparing
outcomes by each additional week (from 34–40 weeks) of EM versus immediate birth. This
study found that birth at 36 weeks gestation was associated with lower perinatal mortality.
Summary statement. The evidence is mixed. One RCT found that early planned birth for
ICP was not associated with improved outcomes, however this study was underpowered to
detect clinically important differences. Evidence from retrospective cohort studies suggests
that planned early birth was associated with a significant reduction in the incidence of still-
births, and that planned birth at 36 weeks gestation was associated with lower perinatal
mortality.
Elevated maternal body mass index
In relation to elevated maternal BMI (�30.0 kg/m2), four retrospective cohort studies were
included [167–170], presenting mixed findings. Wolfe et al. [170] compared maternal and
neonatal outcomes in obese (�30.0 kg/m2), nulliparous women with an unfavourable cervix
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(modified Bishop score < 5) undergoing elective IOL between 39 and 41 weeks (n = 60)
with EM after 39 weeks (n = 410). This study found that IOL was associated with higher
rates of CS (40% vs 25.9%, p = .022), and NICU admissions (18.3% vs 6.3%, p = .001). Other
maternal and neonatal outcomes were similar. These findings were not supported by the
other included studies, described below, which found that IOL was associated with lower CS
rates [167–169].
Kawakita et al. [167] compared the CS rate of elective IOL with EM in morbidly obese
women (BMI�40 kg/m2) between 37 and 41+6 weeks who had singleton pregnancies,
cephalic presentations and no previous CS or other comorbidity. In nulliparous women, elec-
tive IOL was not associated with increased risks of CS and was associated with decreased risks
of macrosomia (2.2% vs 11.0%) at early term and decreased NICU admissions (5.1% vs 8.9%)
at full term. In multiparous women, IOL was associated with a decreased risk of macrosomia
at early term (4.2% vs 14.3%), CS at full term (5.4% vs 7.9%), and composite neonatal outcome
(0% vs 0.6%) at full term.
Both Lee et al. [169] and Pickens et al. [168] compared outcomes between elective IOL and
EM in obese women (BMI�30.0 kg/m2) with singleton pregnancies by analysing a Califor-
nian national dataset. Lee et al. [169] analysed 2007 data and compared outcomes for the two
groups for each gestational age, from 37–40 weeks. This study found that IOL was associated
with lower CS rates, and lower odds of macrosomia. There were no differences in the other
reported outcomes. Similarly, Pickens et al. [168] analysed data from 2007 to 2011, comparing
outcomes for these two groups at 39 and 40 and 41 weeks. This study found that IOL was
associated with reduced CS rates (at 39 weeks gestation, frequencies were 35.9% vs 41.0%,
p =<0.05), reduced composite of severe maternal morbidity (5.6% vs 7.6%, p =<0.05), and
reduced NICU admissions (7.9% vs 10.1%, p =<0.05).
Summary statement. The evidence is mixed and from retrospective cohort studies only.
While some studies indicated that IOL for a high BMI was associated with reduced CS rates
and improved maternal and neonatal outcomes, other studies demonstrated the reverse.
Maternal age
In relation to maternal age, we found two studies to include, one RCT [171] and one retrospec-
tive cohort study [172]. An RCT by Walker et al. [171] tested if IOL at 39 weeks reduces CS
rates for nulliparous women who are� 35 years by comparing outcomes for IOL (n = 305)
with EM (n = 314). This study found no significant differences in the two groups in terms of
CS rates (32% in the IOL group vs 33% in the EM group; RR 0.99, 95% CI 0.87 to 1.14), the
percentage of women who had a vaginal birth with the use of forceps or vacuum (38% vs 33%,
RR 1.30, 95% CI 0.96 to 1.77), the women’s experience of childbirth, or adverse maternal or
neonatal outcomes. There were no maternal or infant deaths.
A retrospective cohort study by Knight et al. [172] compared perinatal mortality between
IOL (at between 39 and 41 weeks) (n = 25,583) and EM (n = 51,744) for nulliparous women
aged� 35 years. Women with comorbidities or previous complicated births were excluded.
IOL at 40 weeks was associated with a lower risk of in-hospital perinatal death (0.08% vs
0.26%; RR 0.33 95% CI 0.13 to 0.80; p = 0.015) and meconium aspiration syndrome (0.44% vs
0.86%; RR 0.52, 95% CI 0.35 to 0.78; p = 0.002), but an increased risk of instrumental vaginal
birth (RR 1.06, 95% CI 1.01 to 1.11; p = 0.020) and CS (RR 1.05, 95% CI 1.01 to 1.09; p =
0.019). A number needed to treat analysis indicated that 562 women would require IOL at 40
weeks to prevent one perinatal death.
Summary statement. Evidence from one RCT indicated that IOL does not improve out-
comes or CS rates for women greater than 35 years, however this study was underpowered to
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identify the effect of IOL on perinatal death. Evidence from a retrospective cohort study sug-
gested that IOL at 40 weeks reduces perinatal mortality.
Maternal cardiac disease
One study, a prospective cohort study, addressed maternal cardiac disease [173]. This study
examined the safety of IOL in women with cardiac disease by comparing outcomes for women
who underwent IOL between 37 and 40 weeks (n = 47) versus EM (n = 74) (spontaneous onset
of labour resulting in vaginal birth or emergency CS). There was no significant difference in
complication rate between the two groups, however the groups were not well matched as
women in the IOL group had more severe cardiac disease than those in the EM group.
Suspected macrosomia
In relation to suspected macrosomia as an indication for women undergoing an IOL, there
were three studies, consisting of a Cochrane review [174], a systematic review and meta-analy-
sis of RCTs and observational studies [175] and one retrospective cohort study [176]. We also
identified a fourth study, a systematic review and meta-analysis, but this review included the
same papers as the Cochrane review (the Cochrane was assessed as higher quality) and was
therefore excluded [177].
The Cochrane review by Boulvain (2016) [174] sought to determine the effects of a policy
of IOL of between 37 and 40 weeks for suspected fetal macrosomia on CS rates and maternal
or perinatal morbidity. The review identified four RCTs [178–181] with a total of 1190
women, 590 in the IOL group and 600 in the EM group. In two of the included trials, women
with diabetes were excluded [179, 180], one trial excluded women treated with insulin, but
included participants who had GDM controlled by diet (10%) [178], whilst the participant
inclusion criteria for the fourth trial was unclear [181]. Women were included when the fetal
weight, estimated by ultrasound examination, was between 4000g and 4500g [180], and
between 4000g and 4750g [179], when the fetus was estimated to weigh >97th percentile
[181], or >95th centile [178]. This review found that compared to EM, IOL had no clear effect
on the risk of CS (RR 0.91, 95% CI 0.76 to 1.09) or instrumental birth (RR 0.86, 95% CI 0.65 to
1.13) but did reduce shoulder dystocia (RR 0.60, 95% CI 0.37 to 0.98) and fetal fracture (any)
(RR 0.20, 95% CI 0.05 to 0.79). There was no strong evidence of any difference between groups
for low infant Apgar scores (<7 at one minute) (RR 1.51, 95% CI 0.25 to 9.02) or low arterial
cord blood pH (RR 1.01, 95% CI 0.46 to 2.22). There were no clear differences between groups
for brachial plexus injury, although this outcome was infrequent. Two studies reported third-
and fourth-degree perineal tears, but only one had estimable data [178]; this study found the
number of women with perineal tears was increased in the IOL group (RR 3.70, 95% CI 1.04 to
13.17). There was no perinatal mortality, and no differences in the groups in terms of the num-
ber of newborns with intraventricular haemorrhage (RR 1.06, 95% CI 0.19 to 5.96), or neonatal
intensive care admissions (RR 0.66, 95% CI 0.35 to 1.24).
The systematic review and meta-analysis by Sanchez-Ramos et al. [175] included two of
the RCTs included in the Cochrane review [179, 180], in addition to nine observational studies
published between 1966 and 2002, with a total of 3751 women (2700 in the IOL group and
1051 in the EM group). The observational and RCT data were analysed separately; since we
have already reported on the RCT findings, we only report the findings of the observational
studies here. Analysis of the non-randomised studies indicates that the risk of CS may be
increased when IOL is undertaken. Women who experienced spontaneous onset of labour had
a lower incidence of CS in comparison to the IOL group (OR 0.39, 95% CI 0.30 to 0.50) and
higher rates of spontaneous vaginal birth (OR 2.07, 95% CI 1.34 to 3.19). No differences were
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noted in rates of operative vaginal births, incidence of shoulder dystocia, or abnormal Apgar
scores, in the analyses of the observational studies.
An observational study by Cheng et al. [176] based on known birthweight presented different
findings. This retrospective cohort study compared the frequency of CS for women who had an
IOL at 39 weeks with a neonatal birthweight of 4000 +/- 125g (birthweight 3875-4125g) with
women who gave birth (following IOL or spontaneous onset of labour) at 40 weeks with birth-
weight 4075–4325g, at 41 weeks with a birthweight at 4275–4525g, or 42 weeks with a birth-
weight of 4475–4725g (assuming an intrauterine fetal weight gain of 200g per additional week of
gestation). The frequency of CS in the IOL group was lower compared with women who gave
birth at a later gestational age (35.2% versus 40.9%; OR 1.25, 95% CI 1.17 to 1.33). This study
concluded that in the setting of macrosomia and known birthweight, IOL may reduce CS rates.
Summary statement. Evidence from four RCTs included in a Cochrane review indicates
that there appears to be little difference between IOL versus EM in terms of maternal and neo-
natal outcomes for women with suspected macrosomia.
Fetal gastroschisis
In relation to known fetal gastroschisis, we identified two studies for inclusion, a Cochrane
review [182] and a retrospective cohort study [183]. The Cochrane review [182] assessed the
effects of elective preterm birth (<37 weeks) for fetal gastroschisis, and identified one RCT for
inclusion [184]. This RCT assessed whether planned birth at 36 weeks reduces postnatal mor-
bidity without exposing the infant to the added risks of prematurity by comparing outcomes
for IOL at 36 weeks (n = 21) and spontaneous onset of labour (n = 21). The trial found no sig-
nificant benefits or adverse effects associated with elective preterm birth, however, it was
underpowered to detect clinically important differences. Two babies died in the planned birth
group versus none in the spontaneous group. Seven women (33%) in the planned birth group
and nine women (43%) in the spontaneous group had a CS (RR 0.78, 95% CI 0.36 to 1.70).
There were no statistical differences in birthweight, ventilation requirements, necrotising
enterocolitis and requirements for repeat surgery between the two groups. The average gesta-
tional age at birth was 35.8 weeks in the planned birth group and 36.7 weeks in the spontane-
ous onset of labour group.
An observational study by Al-Kaff et al. [183] analysed data from a national dataset in Can-
ada that included 519 fetuses diagnosed with isolated gastroschisis between 2005 and 2013.
This study compared outcomes for mode of birth (spontaneous labour, n = 190; IOL, n = 280;
CS, n = 49) and timing of birth (�35 weeks, n = 8; 36–37 weeks, n = 193;�38 weeks, n = 69).
Neither mode nor timing of birth were associated with significant benefits or adverse effects.
Planned IOL was not associated with decreased length of neonatal stay, total parenteral nutri-
tion duration, or risk of the composite adverse outcome (RR 1.7, 95% CI 0.1 to 3.2) compared
with birth following spontaneous onset of labour. Planned birth at 36–37 weeks was not associ-
ated with decreased length of neonatal stay, total parenteral nutrition duration or risk of com-
posite outcome (RR 2.3, 95% CI 0.8 to 5.4) compared with planned birth at 38 weeks. Findings
support awaiting the onset of spontaneous labour in pregnancies that are complicated by fetal
gastroschisis.
Summary statement. There was no evidence to support IOL for women who have preg-
nancies complicated by fetal gastroschisis.
Suspected fetal compromise
We identified four studies in relation to fetal compromise, consisting of two Cochrane reviews
[185, 186] and two retrospective cohort studies [187, 188]. The included studies regarded
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compromise in the context of oligohydramnios [185, 187] as well as suspected IUGR [185,
186, 188]. The Cochrane review by Stock et al. [186] assessed the effects of immediate versus
deferred birth of preterm babies with suspected fetal compromise on neonatal, maternal and
long-term outcomes. This review included one trial of 548 women (588 babies) with pregnan-
cies between 24 and 36 weeks and compared the outcomes for immediate birth (by IOL or CS)
(n = 296) versus deferred birth (n = 291) (i.e. a set period of time until test results worsen, or
until spontaneous onset of labour) [139, 189]. More women in the immediate birth group had
a CS (RR 1.15, 95% CI 1.07 to 1.24), there were more babies who were ventilated for more than
24 hours (RR 1.54, 95% CI 1.20 to 1.97), and more had cerebral palsy at or after two years of
age (RR 5.88, 95% CI 1.33 to 26.02). There was no real difference for other neonatal morbidity
and mortality outcomes, perinatal mortality (RR 1.17, 95% CI 0.67 to 2.04), the composite out-
come of death or disability at or after two years of age (RR 1.22, 95% CI 0.85 to 1.75), neurode-
velopment impairment at or after two years (RR 1.72, 95% CI 0.86 to 3.41), death at or after
two years of age (RR 1.04, 95% CI 0.66 to 1.63), or death or disability in childhood (6–13 years
of age) (RR 0.82, 95% CI 0.48 to 1.40). The gestational age at birth was a median of four days
earlier in women randomised to immediate birth. The review concluded that for preterm
babies with suspected compromise and uncertainty about whether to hasten the birth or not,
there appeared to be no benefit to immediate birth.
The Cochrane review by Bond et al. [185] assessed the effects of immediate birth (via IOL or
CS) versus EM (until spontaneous onset of labour or planned early birth if it became necessary)
for suspected fetal compromise at term (� 37 weeks) on neonatal, maternal and long-term out-
comes. This review identified three RCTs for inclusion, with a total of 546 participants, of which
269 were randomised to immediate birth and 277 to EM. Two of the trials compared outcomes
in 492 women whose pregnancies were complicated by IUGR [190–192], and one trial included
54 women with oligohydramnios [193]. This review found no difference in neonatal outcomes
including perinatal mortality (no deaths in either group), major neonatal morbidity (RR 0.15,
95% CI 0.01 to 2.81), or neurodevelopmental disability/impairment at two years of age (RR 2.04,
95% CI 0.62 to 6.69). There was no difference in the risk of necrotising enterocolitis or meconium
aspiration. There was also no difference in maternal mortality (RR 3.07, 5% CI 0.13 to 74.87), sig-
nificant maternal morbidity (RR 0.92, 95% CI 0.38 to 2.22), CS rates (RR 1.02, 95% CI 0.65 to
1.59) or secondary maternal outcomes. Significantly more infants in the planned early birth
group were admitted to an intermediate care nursery (RR 1.28, 95% CI 1.02 to 1.61). The gesta-
tional age at birth was an average of 10 days earlier in women randomised to immediate birth.
A retrospective cohort study by Rabinovich et al. [188] compared outcomes for IOL
(n = 1428) versus EM (n = 804) between 34 and 38 weeks for IUGR. This study found that the
IOL group had lower stillbirth and neonatal death rates (p< .001), higher 1 and 5 min Apgar
scores and higher vaginal birth rates. IOL at 37 weeks protected from stillbirth but not from
adverse composite neonatal outcomes. A retrospective cohort study by Brzezinski-Sinai et al.
[187] compared outcomes for women with isolated oligohydramnios between 34 and 36.6
weeks who went into labour spontaneously (n = 33) versus those who underwent IOL
(n = 111). Spontaneous labour was associated with statistically significant higher rates of CS
(p< .001), as well as higher rates of maternal infection, chorioamnionitis, and transitory
tachypnoea of the newborn. This study concluded that IOL may be beneficial to both the neo-
nate and the mother; however some caution needs to be used interpreting these findings as the
study was assessed as of moderate risk of bias.
Summary statement. For preterm babies with suspected compromise and uncertainty
about whether to plan birth early or not, there appears to be no benefit to immediate birth.
However, included studies were largely underpowered and had different definitions of what is
considered fetal compromise.
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Discussion
The majority of indications for IOL are not supported by strong evidence. While there is high
quality evidence in relation to IOL for post-term pregnancy, hypertension/preeclampsia and
PROM, for all other indications there were conflicting findings and/or insufficient power to
provide definitive evidence. A summary of the evidence and recommendations for future
research are included in Table 3.
We did not identify any studies for inclusion in relation to fetal alloimmune disease, ante-
partum haemorrhage, chorioamnionitis (including suspected), or maternal mental health indi-
cations, and only one study in relation to maternal cardiac disease, which did not identify any
adverse nor beneficial effects associated with IOL. This may be due to the low incidence of
these issues and therefore the challenges in undertaking research. Clinical judgement rather
than high level evidence will need to continue to drive practice.
The uncertainty in the evidence identified by this review raises questions about the implica-
tions for evidence in practice and the development of guidelines. While variations in clinical prac-
tice is often attributed to suboptimal guideline adherence [202–204], there is an increasing
recognition that this may also be due to a shortage of clear clinical guidelines that provide consis-
tent recommendations that are evidence based [203, 205, 206]. Specific to IOL a recent review of
guidelines identified significant variation across guidelines in what are considered acceptable indi-
cations for IOL [17]. This variation can be understood in light of the evidence gaps in this space.
While further high quality evidence needs to be developed, there are challenges associated
with RCTs, in terms of recruitment and funding. Until this evidence is available, there is a
need to develop a better understanding of how to provide evidence-based care when the evi-
dence is unclear. Clinical decision making should be informed by evidence from RCTs and
cohort studies, but evolve to include the women’s experience of care and preferences and
include a process of shared-decision making. While the importance of shared decision making
between women and practitioners is increasingly recognised [207, 208], how shared decision
making is best performed in the context of uncertainty or ambiguity remains less clear [209].
To support and inform evidence based care, more research is needed into shared decision
making in a context of uncertainty. Furthermore, the experiences and preferences of women is
largely absent from this literature, and RCTs that include women’s experience of care as an
outcome are required.
This review presents a comprehensive overview of the literature in relation to IOL. How-
ever, we could not access the full text of a small number of articles, and we did not include
studies that were not in English that may have been relevant to our findings. Furthermore, in
accordance with the scoping methodology [29, 210], the quality assessment of the included
studies was minimal and largely limited to an assessment of bias. Strengths of this study were
that two authors reviewed each of the articles and recognised tools for data extraction and bias
detection were used.
Conclusion
A large proportion of pregnant women have IOL at or near term, sometimes for indications
that are well supported by evidence, and sometimes not. This study systematically mapped the
available evidence for common indications for IOL. While for some indications, IOL is highly
recommended, a number of common indications do not have strong supporting evidence.
Overall, few RCTs have evaluated the various indications for IOL, and researchers and funding
agencies should prioritise studies of sufficient power that can help to guide care in these situa-
tions. However, the entrenched nature of some IOL indications even when not well supported
by evidence does present practical difficulties to RCT recruitment. Women should be provided
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Table 3. Evidence summary and recommendations for future research.
Post-term pregnancy
Evidence:
1. IOL versus EM, beyond 41–42 weeks is associated with fewer perinatal deaths and reduced CS rates. Therefore,
although the number needed to treat is high for prevention of perinatal mortality, at approximately 450 IOL for
every death prevented [6], and rate of assisted vaginal birth increased, post-term pregnancy is likely to remain a
routine IOL indication.
2. The available evidence for optimal timing of IOL (41+ versus 42+) remains limited.
Future directions:
1. More studies with an adequate sample size would be ideal to improve the granularity of the data at different
gestations. While further research is required, enthusiasm for post-term pregnancy trials may be low after the
recently published ARRIVE RCT, where reduction in CS rates (and no evidence of maternal or infant harm) was
found in women undergoing IOL at 39+ weeks versus EM [18]. Furthermore, given that offering IOL at 41+
weeks is ingrained into policy and practice in most high-income settings [13, 16, 194] it is likely any sufficiently
powered RCT would need to be conducted in a low-to-middle-income country setting. These findings may then
not necessarily be applicable to high-income settings.
PROM at term
Evidence:
1. Evidence from a Cochrane review that included 23 RCTs indicates that planned early birth may help reduce
maternal and neonatal infections without increasing CS rates. The quality of the evidence was low due to many
studies being at high risk of bias.
Future directions:
1. Ideally further research to assess the benefits versus harms of planned early birth would be performed, particularly
in the early term (37–38 week) group. However, evidence that risk of chorioamnionitis increases from
approximately 12 hours after term PROM [195], and associations of chorioamnionitis with the serious long-term
morbidity of cerebral palsy, in addition to the short term morbidities assessed in the included studies [196],
means there is unlikely to be clinical equipoise to perform such trials.
Pre-term PROM
Evidence:
1. Evidence from a Cochrane review that included 12 RCTs indicated that early birth increased the risk of infant
death after birth, respiratory problems and NICU admissions, and CS rates without a clinically important
difference in the incidence of neonatal sepsis. Early birth was associated with decreased incidence of
chorioamnionitis.
2. For women with PROM <37 weeks with no contraindications to continuing the pregnancy, a policy of EM with
careful monitoring was associated with better perinatal outcomes.
Future directions:
1. More research that explores the risk benefit ratio of early birth (late preterm) on long term developmental
outcomes is required.
Hypertension
Evidence:
1. There was limited high quality evidence to inform decisions about optimal timing of birth. There was little or no
agreement on the timing of birth for women with chronic hypertension, gestational hypertension or mild
preeclampsia at term. Some evidence indicated that planned birth between 38 and 39 weeks was associated with
the lowest maternal and neonatal morbidity/mortality for both women with gestational hypertension and those
with chronic hypertension.
2. In preeclampsia or gestational hypertension, maternal morbidity was lower in RCTs comparing immediate
(versus delayed) birth anytime from 34 weeks, however infant morbidity may be higher, particularly prior to 37
weeks.
3. The vast majority of studies regarded severe preeclampsia remote from term. There was evidence that indicated
that EM for severe preeclampsia remote from term increases birthweight and reduces neonatal morbidity.
4. In relation to IOL versus CS, evidence indicated that while IOL is associated with high rates of CS, it is not
associated with increased harm and should be considered a reasonable option.
Future directions:
1. Overall the strength of the evidence was weak, particularly regarding preterm preeclampsia and timing of birth at
term for chronic hypertension and gestational hypertension, and more research is needed.
(Continued)
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Table 3. (Continued)
Diabetes
Evidence:
1. There was little quality evidence to inform management between IOL at term or EM, and the little evidence that
was available was limited to GDM. Only one relevant study included women with pre-existing diabetes (Type I
and Type 2), consisting of only 13 women.
Future directions:
• Further prospective cohort and RCT studies are required.
Twin pregnancies
Evidence:
• The existing evidence does not definitively indicate that early planned birth for uncomplicated twin pregnancy
improves outcomes.
• While some cohort studies found that IOL in twin pregnancies increases the risk of CS compared to spontaneous
labour onset, other studies found the reverse.
• Evidence from two RCTs found non-significant improvements in composite neonatal and maternal outcomes
with planned birth at 37 weeks.
Future directions:
1. More research is required. However, given population data suggests increased stillbirth risk in twin pregnancy
beyond 37 weeks, there is unlikely to be uptake for trials of birth versus EM at later gestations [156]. Complicating
interpretation of the twin pregnancy evidence is the non-reporting, missing data, or lack of power of the
underlying studies to examine monochorionic (MCDA) versus dichorionic (DCDA) data. MCDA twins have
substantially different risks to DCDA, including consequences of late intrauterine death of one twin on the other
twin, making grouping of MCDA and DCDA in timing of birth studies problematic [197].
Intrahepatic cholestasis of pregnancy
Evidence:
1. Evidence from one RCT indicated that early planned birth was not associated with improved outcomes, however
this study was underpowered to detect clinically important differences.
2. Evidence from retrospective cohort studies suggested that planned early birth was associated with a significant
reduction in the incidence of stillbirths, and that planned birth at 36 weeks gestation was associated with lower
perinatal mortality.
Future directions:
1. Further well-conducted cohort studies or RCTs of early term (37–38 weeks) versus full-term (39–40 weeks) birth
are recommended. Timing of birth RCTs may not be ethical in the subgroup of women with high bile acids
(>40μmol/L), where there is some cohort data to suggest an increased stillbirth risk directly related to ICP [198,
199], and would certainly be hard to justify in those with bile acid levels >100 μmol/L where cohort evidence for
increased stillbirth risk is strong [200]. However for the majority of cholestasis cases, where bile acid levels are 10–
40 μmol/L, an elevated stillbirth risk above background is not proven [199, 200], and early term birth with its
potential adverse infant neurodevelopmental sequelae may not be justified [201].
Maternal elevated BMI
Evidence:
1. Evidence from retrospective cohort studies presented mixed findings. While some studies indicated that IOL was
associated with reduced CS rates and improved maternal and neonatal outcomes, other studies demonstrated the
reverse.
Future directions:
1. Further prospective cohort studies and RCTs are required.
Maternal age
Evidence:
1. Evidence from one RCT indicated that IOL does not improve outcomes or CS rates for women greater than 35
years, however this study was underpowered to identify the effect of IOL on perinatal death.
2. Evidence from a retrospective cohort study suggested that IOL at 40 weeks reduces perinatal mortality.
Future directions:
1. Further research is required.
(Continued)
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with the best available evidence to help them make an informed choice about the risks and
benefits of IOL. Clinicians should use the best available evidence to inform decision making
and acknowledge when insufficient evidence is available.
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Suspected macrosomia
Evidence:
1. Evidence from four RCTs included in a Cochrane review indicates that there appears to be little difference
between IOL versus EM in terms of maternal and neonatal outcomes, but most included studies were
underpowered.
2. Evidence from cohort studies present mixed findings, with some indicating that IOL is associated with a
reduction in CS rates, and some indicating IOL is associated with increased CS rates.
Future directions:
1. Further adequately powered research is required.
Fetal gastroschisis
Evidence:
1. Neither the Cochrane review (with one RCT included) nor the retrospective cohort study found any significant
benefits or adverse effects associated with IOL.
2. While the RCT was underpowered, these findings support EM in pregnancies that are complicated by fetal
gastroschisis.
Future directions:
1. As more women globally are exposed to antenatal ultrasound, more babies may be identified in utero with fetal
gastroschisis. Therefore, further research is necessary to determine the impact of IOL especially in low to middle
income settings.
Fetal compromise
Evidence:
1. Evidence from RCTs included in Cochrane reviews indicates that for preterm babies with suspected compromise
and uncertainty about whether to plan give birth early or not, there appears to be no benefit to immediate birth.
However, these studies were largely underpowered.
Future directions:
1. Further adequately powered research is required.
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